ONTOLOGY REPORT - ANNOTATIONS
| Term: | raloxifene |
|
| Accession: | CHEBI:8772
|
browse the term
|
| Definition: | A benzothiophene that has formula C28H27NO4S. |
| Synonyms: | exact_synonym: | [6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone |
| | related_synonym: | (2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone; C28H27NO4S; InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2; InChIKey=GZUITABIAKMVPG-UHFFFAOYSA-N; LY 139481; Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1; raloxifeno; raloxifenum |
| | xref_casrn: | 84449-90-1 |
| | xref: | Beilstein:4890356 "Beilstein Registry Number"; ChemIDplus:84449-90-1 "CAS Registry Number"; DrugBank:DB00481 "DrugBank"; KEGG COMPOUND:C07228 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D020849 |
| | xref: | Patent:EP62503 "Patent"; Patent:US4418068 "Patent" |
|
|
raloxifene
|
| G |
1810011O10Rik |
RIKEN cDNA 1810011O10 gene |
|
multiple interactions |
ISO |
8 |
25,548,088 |
25,549,418 |
RGD:6480464 |
CTD |
| G |
2010111I01Rik |
RIKEN cDNA 2010111I01 gene |
|
multiple interactions |
ISO |
13 |
63,116,294 |
63,400,964 |
RGD:6480464 |
CTD |
| G |
2610018G03Rik |
RIKEN cDNA 2610018G03 gene |
|
decreases expression |
ISO |
X |
48,194,613 |
48,245,033 |
RGD:6480464 |
CTD |
| G |
2810417H13Rik |
RIKEN cDNA 2810417H13 gene |
|
decreases expression |
ISO |
9 |
65,738,130 |
65,751,358 |
RGD:6480464 |
CTD |
| G |
5830404H04Rik |
RIKEN cDNA 5830404H04 gene |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
5830404H04Rik |
RIKEN cDNA 5830404H04 gene |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
8430408G22Rik |
RIKEN cDNA 8430408G22 gene |
|
decreases expression |
ISO |
6 |
116,600,702 |
116,602,865 |
RGD:6480464 |
CTD |
| G |
Aatk |
apoptosis-associated tyrosine kinase |
|
increases expression |
ISO |
11 |
119,868,627 |
119,908,029 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects activity |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
5 |
8,660,092 |
8,748,570 |
RGD:6480464 |
CTD |
| G |
Abcb9 |
ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
|
affects expression |
ISO |
5 |
124,511,866 |
124,545,807 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
ISO |
16 |
14,361,653 |
14,474,968 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
|
affects expression |
ISO |
17 |
31,194,639 |
31,254,929 |
RGD:6480464 |
CTD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
affects expression |
ISO |
9 |
122,260,734 |
122,290,641 |
RGD:6480464 |
CTD |
| G |
Ace |
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
decreases expression |
ISO |
11 |
105,829,261 |
105,851,259 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
ISO |
8 |
47,556,396 |
47,621,404 |
RGD:6480464 |
CTD |
| G |
Acvrl1 |
activin A receptor, type II-like 1 |
|
increases expression |
ISO |
15 |
100,958,968 |
100,975,767 |
RGD:6480464 |
CTD |
| G |
Adam19 |
a disintegrin and metallopeptidase domain 19 (meltrin beta) |
|
multiple interactions |
ISO |
11 |
45,869,489 |
45,960,845 |
RGD:6480464 |
CTD |
| G |
Adam22 |
a disintegrin and metallopeptidase domain 22 |
|
decreases expression |
ISO |
5 |
8,072,352 |
8,368,081 |
RGD:6480464 |
CTD |
| G |
Adamtsl3 |
ADAMTS-like 3 |
|
affects expression |
ISO |
7 |
89,484,204 |
89,762,958 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 |
|
affects expression |
ISO |
13 |
68,758,920 |
69,138,419 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
affects expression |
ISO |
17 |
93,598,762 |
93,604,831 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
increases expression |
ISO |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
16 |
23,146,609 |
23,158,041 |
RGD:6480464 |
CTD |
| G |
Adora2a |
adenosine A2a receptor |
|
increases expression |
ISO |
10 |
74,779,688 |
74,797,533 |
RGD:6480464 |
CTD |
| G |
Adora2b |
adenosine A2b receptor |
|
multiple interactions |
ISO |
11 |
62,062,486 |
62,079,954 |
RGD:6480464 |
CTD |
| G |
Adra1a |
adrenergic receptor, alpha 1a |
|
decreases expression |
ISO |
14 |
67,254,095 |
67,352,166 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
increases expression |
ISO |
11 |
5,761,869 |
5,772,228 |
RGD:6480464 |
CTD |
| G |
Ago2 |
argonaute RISC catalytic subunit 2 |
|
affects expression |
ISO |
15 |
72,932,055 |
73,015,377 |
RGD:6480464 |
CTD |
| G |
Ago2 |
argonaute RISC catalytic subunit 2 |
|
multiple interactions |
ISO |
15 |
72,932,055 |
73,015,377 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
8 |
127,080,487 |
127,093,607 |
RGD:6480464 |
CTD |
| G |
Ahnak |
AHNAK nucleoprotein (desmoyokin) |
|
decreases expression |
ISO |
19 |
9,063,774 |
9,151,409 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl-hydrocarbon receptor |
|
multiple interactions |
ISO |
12 |
36,182,651 |
36,219,661 |
RGD:6480464 |
CTD |
| G |
Ak3 |
adenylate kinase 3 |
|
affects expression |
ISO |
19 |
29,095,322 |
29,122,392 |
RGD:6480464 |
CTD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
affects expression |
ISO |
11 |
88,692,106 |
88,725,900 |
RGD:6480464 |
CTD |
| G |
Akap1 |
A kinase (PRKA) anchor protein 1 |
|
multiple interactions |
ISO |
11 |
88,692,106 |
88,725,900 |
RGD:6480464 |
CTD |
| G |
Akr7a5 |
aldo-keto reductase family 7, member A5 (aflatoxin aldehyde reductase) |
|
affects expression |
ISO |
4 |
138,866,659 |
138,874,701 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
decreases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
|
affects expression |
ISO |
X |
146,981,960 |
147,005,165 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
multiple interactions |
ISO |
16 |
52,249,109 |
52,453,110 |
RGD:6480464 |
CTD |
| G |
Amigo2 |
adhesion molecule with Ig like domain 2 |
|
multiple interactions |
ISO |
15 |
97,074,505 |
97,077,718 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin-like 2 |
|
affects expression |
ISO |
9 |
102,620,134 |
102,635,747 |
RGD:6480464 |
CTD |
| G |
Ang |
angiogenin, ribonuclease, RNase A family, 5 |
|
increases expression |
ISO |
14 |
51,710,752 |
51,721,684 |
RGD:6480464 |
CTD |
| G |
Angptl2 |
angiopoietin-like 2 |
|
affects expression |
ISO |
2 |
33,071,481 |
33,103,234 |
RGD:6480464 |
CTD |
| G |
Angptl7 |
angiopoietin-like 7 |
|
decreases expression |
ISO |
4 |
147,869,389 |
147,874,571 |
RGD:6480464 |
CTD |
| G |
Ank3 |
ankyrin 3, epithelial |
|
affects expression |
ISO |
10 |
68,996,456 |
69,490,184 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
|
multiple interactions |
ISO |
19 |
36,186,455 |
36,194,334 |
RGD:6480464 |
CTD |
| G |
Ankrd28 |
ankyrin repeat domain 28 |
|
multiple interactions |
ISO |
14 |
32,513,201 |
32,643,601 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
multiple interactions |
ISO |
1 |
58,086,813 |
58,163,254 |
RGD:6480464 |
CTD |
| G |
Aox1 |
aldehyde oxidase 1 |
|
decreases activity |
ISO |
1 |
58,086,813 |
58,163,254 |
RGD:6480464 |
CTD |
| G |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
|
affects expression |
ISO |
8 |
112,302,540 |
112,384,835 |
RGD:6480464 |
CTD |
| G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
increases expression |
ISO |
14 |
51,544,696 |
51,546,813 |
RGD:6480464 |
CTD |
| G |
Apex1 |
apurinic/apyrimidinic endonuclease 1 |
|
multiple interactions |
ISO |
14 |
51,544,696 |
51,546,813 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
increases expression |
ISO |
16 |
31,296,278 |
31,314,682 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
95,345,089 |
95,512,486 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
decreases expression |
ISO |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
multiple interactions |
ISO |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
multiple interactions |
EXP |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
EXP |
5 |
91,568,641 |
91,577,458 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
affects expression |
ISO |
3 |
121,656,244 |
121,719,072 |
RGD:6480464 |
CTD |
| G |
Arid5a |
AT rich interactive domain 5A (MRF1-like) |
|
multiple interactions |
ISO |
1 |
36,364,578 |
36,380,874 |
RGD:6480464 |
CTD |
| G |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
|
affects expression |
ISO |
10 |
67,558,341 |
67,741,474 |
RGD:6480464 |
CTD |
| G |
Arl1 |
ADP-ribosylation factor-like 1 |
|
affects expression |
ISO |
10 |
88,194,159 |
88,205,947 |
RGD:6480464 |
CTD |
| G |
Arl4c |
ADP-ribosylation factor-like 4C |
|
affects expression |
ISO |
1 |
90,594,800 |
90,598,766 |
RGD:6480464 |
CTD |
| G |
Arl4c |
ADP-ribosylation factor-like 4C |
|
multiple interactions |
ISO |
1 |
90,594,800 |
90,598,766 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression |
ISO |
7 |
91,394,788 |
91,510,183 |
RGD:6480464 |
CTD |
| G |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
|
multiple interactions |
ISO |
13 |
3,633,322 |
3,651,025 |
RGD:6480464 |
CTD |
| G |
Asns |
asparagine synthetase |
|
decreases expression |
ISO |
6 |
7,625,171 |
7,643,182 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
ISO |
1 |
192,994,175 |
193,007,212 |
RGD:6480464 |
CTD |
| G |
Atf7ip |
activating transcription factor 7 interacting protein |
|
increases expression |
ISO |
6 |
136,467,372 |
136,555,900 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression |
ISO |
3 |
101,380,146 |
101,408,580 |
RGD:6480464 |
CTD |
| G |
Atp9a |
ATPase, class II, type 9A |
|
affects expression |
ISO |
2 |
168,459,938 |
168,567,300 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
decreases expression |
ISO |
2 |
172,181,696 |
172,196,006 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases cleavage |
ISO |
19 |
7,016,345 |
7,026,383 |
RGD:6480464 |
CTD |
| G |
Bai2 |
brain-specific angiogenesis inhibitor 2 |
|
affects expression |
ISO |
4 |
129,662,408 |
129,699,877 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
decreases expression |
ISO |
17 |
27,156,757 |
27,165,571 |
RGD:6480464 |
CTD |
| G |
Bax |
BCL2-associated X protein |
|
affects expression |
ISO |
7 |
52,717,065 |
52,722,268 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
affects expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
decreases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases expression |
ISO |
2 |
127,951,774 |
127,988,283 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B cell leukemia/lymphoma 3 |
|
multiple interactions |
EXP |
7 |
20,393,811 |
20,408,104 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B cell leukemia/lymphoma 6 |
|
increases expression |
ISO |
16 |
23,965,138 |
23,988,698 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
decreases expression |
ISO |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
increases expression |
ISO |
X |
70,728,974 |
70,741,275 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
increases expression |
ISO |
X |
70,728,974 |
70,741,275 |
RGD:6480464 |
CTD |
| G |
Birc3 |
baculoviral IAP repeat-containing 3 |
|
multiple interactions |
ISO |
9 |
7,848,699 |
7,873,170 |
RGD:6480464 |
CTD |
| G |
Blzf1 |
basic leucine zipper nuclear factor 1 |
|
decreases expression |
ISO |
1 |
166,219,931 |
166,237,615 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
affects expression |
ISO |
2 |
172,695,187 |
172,765,794 |
RGD:6480464 |
CTD |
| G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
|
affects expression |
ISO |
4 |
136,436,060 |
136,442,092 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
EXP |
17 |
57,343,396 |
57,367,559 |
RGD:6480464 |
CTD |
| G |
Cabin1 |
calcineurin binding protein 1 |
|
increases expression |
ISO |
10 |
75,108,855 |
75,227,102 |
RGD:6480464 |
CTD |
| G |
Cacna1h |
calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
decreases expression |
EXP |
17 |
25,511,232 |
25,570,728 |
RGD:6480464 |
CTD |
| G |
Cacna1i |
calcium channel, voltage-dependent, alpha 1I subunit |
|
decreases expression |
EXP |
15 |
80,117,668 |
80,228,722 |
RGD:6480464 |
CTD |
| G |
Calb2 |
calbindin 2 |
|
increases expression |
ISO |
8 |
112,666,438 |
112,692,106 |
RGD:6480464 |
CTD |
| G |
Cald1 |
caldesmon 1 |
|
decreases expression |
ISO |
6 |
34,548,500 |
34,637,173 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
12 |
101,437,751 |
101,448,016 |
RGD:6480464 |
CTD |
| G |
Cap2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
|
decreases expression |
ISO |
13 |
46,597,272 |
46,745,650 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2 |
|
affects expression |
ISO |
1 |
184,397,390 |
184,447,614 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
affects expression |
ISO |
9 |
66,561,493 |
66,614,652 |
RGD:6480464 |
CTD |
| G |
Car12 |
carbonic anyhydrase 12 |
|
multiple interactions |
ISO |
9 |
66,561,493 |
66,614,652 |
RGD:6480464 |
CTD |
| G |
Car4 |
carbonic anhydrase 4 |
|
affects expression |
ISO |
11 |
84,771,256 |
84,779,556 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
affects expression |
ISO |
15 |
78,605,566 |
78,633,472 |
RGD:6480464 |
CTD |
| G |
Caskin2 |
CASK-interacting protein 2 |
|
multiple interactions |
ISO |
11 |
115,660,666 |
115,674,906 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
affects expression |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
ISO |
19 |
56,471,619 |
56,516,834 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
affects expression |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
6 |
17,256,370 |
17,291,324 |
RGD:6480464 |
CTD |
| G |
Cbx1 |
chromobox 1 |
|
decreases expression |
ISO |
11 |
96,650,450 |
96,669,954 |
RGD:6480464 |
CTD |
| G |
Cbx3 |
chromobox 3 |
|
decreases expression |
ISO |
6 |
51,420,615 |
51,433,703 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects expression |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases activity |
ISO |
11 |
81,849,079 |
81,850,954 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
multiple interactions |
ISO |
1 |
83,113,341 |
83,115,742 |
RGD:6480464 |
CTD |
| G |
Ccl20 |
chemokine (C-C motif) ligand 20 |
|
affects expression |
ISO |
1 |
83,113,341 |
83,115,742 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
decreases expression |
ISO |
11 |
83,461,345 |
83,462,880 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
decreases expression |
ISO |
11 |
83,339,280 |
83,344,020 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
3 |
36,463,787 |
36,470,918 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
13 |
101,548,694 |
101,556,441 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccng2 |
cyclin G2 |
|
increases expression |
ISO |
5 |
93,696,599 |
93,705,257 |
RGD:6480464 |
CTD |
| G |
Cd200 |
CD200 antigen |
|
decreases expression |
ISO |
16 |
45,382,248 |
45,409,166 |
RGD:6480464 |
CTD |
| G |
Cd24a |
CD24a antigen |
|
increases expression |
ISO |
10 |
43,298,975 |
43,304,071 |
RGD:6480464 |
CTD |
| G |
Cd3g |
CD3 antigen, gamma polypeptide |
|
affects expression |
ISO |
9 |
44,777,655 |
44,788,514 |
RGD:6480464 |
CTD |
| G |
Cd40 |
CD40 antigen |
|
multiple interactions |
EXP |
2 |
164,881,136 |
164,897,154 |
RGD:6480464 |
CTD |
| G |
Cd52 |
CD52 antigen |
|
affects expression |
ISO |
4 |
133,649,453 |
133,650,988 |
RGD:6480464 |
CTD |
| G |
Cd74 |
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) |
|
affects expression |
ISO |
18 |
60,963,503 |
60,972,306 |
RGD:6480464 |
CTD |
| G |
Cd80 |
CD80 antigen |
|
multiple interactions |
EXP |
16 |
38,459,013 |
38,487,015 |
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 antigen |
|
multiple interactions |
EXP |
16 |
36,603,955 |
36,666,163 |
RGD:6480464 |
CTD |
| G |
Cd8a |
CD8 antigen, alpha chain |
|
affects expression |
ISO |
6 |
71,323,421 |
71,329,165 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects expression |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
multiple interactions |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
affects expression |
ISO |
18 |
16,747,386 |
16,967,558 |
RGD:6480464 |
CTD |
| G |
Cdh6 |
cadherin 6 |
|
affects expression |
ISO |
15 |
12,963,955 |
13,103,394 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions |
ISO |
11 |
80,290,548 |
80,294,681 |
RGD:6480464 |
CTD |
| G |
Cdk5rap3 |
CDK5 regulatory subunit associated protein 3 |
|
affects expression |
ISO |
11 |
96,769,100 |
96,777,795 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
ISO |
6 |
134,870,419 |
134,875,543 |
RGD:6480464 |
CTD |
| G |
Cdo1 |
cysteine dioxygenase 1, cytosolic |
|
multiple interactions |
ISO |
18 |
46,872,859 |
46,887,996 |
RGD:6480464 |
CTD |
| G |
Cdon |
cell adhesion molecule-related/down-regulated by oncogenes |
|
affects expression |
ISO |
9 |
35,259,661 |
35,315,237 |
RGD:6480464 |
CTD |
| G |
Cebpa |
CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression |
ISO |
7 |
35,904,312 |
35,906,947 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
decreases expression |
ISO |
5 |
30,969,275 |
30,977,199 |
RGD:6480464 |
CTD |
| G |
Cers6 |
ceramide synthase 6 |
|
multiple interactions |
ISO |
2 |
68,699,614 |
68,949,347 |
RGD:6480464 |
CTD |
| G |
Cfd |
complement factor D (adipsin) |
|
increases expression |
ISO |
10 |
79,353,598 |
79,355,401 |
RGD:6480464 |
CTD |
| G |
Chrd |
chordin |
|
affects expression |
ISO |
16 |
20,733,200 |
20,742,457 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
multiple interactions |
EXP |
9 |
107,199,020 |
107,204,292 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases activity |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
multiple interactions |
ISO |
12 |
112,907,566 |
112,910,549 |
RGD:6480464 |
CTD |
| G |
Clcn4-2 |
chloride channel 4-2 |
|
multiple interactions |
ISO |
7 |
7,235,027 |
7,252,222 |
RGD:6480464 |
CTD |
| G |
Clcn6 |
chloride channel 6 |
|
increases expression |
ISO |
4 |
147,380,593 |
147,412,876 |
RGD:6480464 |
CTD |
| G |
Clic4 |
chloride intracellular channel 4 (mitochondrial) |
|
increases expression |
ISO |
4 |
134,769,884 |
134,828,675 |
RGD:6480464 |
CTD |
| G |
Clstn1 |
calsyntenin 1 |
|
decreases expression |
ISO |
4 |
148,960,747 |
149,022,008 |
RGD:6480464 |
CTD |
| G |
Cltb |
clathrin, light polypeptide (Lcb) |
|
affects expression |
ISO |
13 |
54,694,300 |
54,712,633 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
EXP |
14 |
66,587,320 |
66,600,382 |
RGD:6480464 |
CTD |
| G |
Col11a1 |
collagen, type XI, alpha 1 |
|
affects expression |
ISO |
3 |
113,733,458 |
113,923,244 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
decreases expression |
EXP |
6 |
4,455,697 |
4,491,543 |
RGD:6480464 |
CTD |
| G |
Col26a1 |
collagen, type XXVI, alpha 1 |
|
increases expression |
ISO |
5 |
137,217,634 |
137,358,977 |
RGD:6480464 |
CTD |
| G |
Col5a1 |
collagen, type V, alpha 1 |
|
affects expression |
ISO |
2 |
27,741,945 |
27,895,030 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
affects expression |
ISO |
1 |
45,431,176 |
45,560,127 |
RGD:6480464 |
CTD |
| G |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
|
decreases expression |
ISO |
9 |
98,464,150 |
98,488,794 |
RGD:6480464 |
CTD |
| G |
Cpb2 |
carboxypeptidase B2 (plasma) |
|
decreases expression |
ISO |
14 |
75,642,094 |
75,683,362 |
RGD:6480464 |
CTD |
| G |
Cpe |
carboxypeptidase E |
|
affects expression |
ISO |
8 |
67,071,339 |
67,171,837 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
increases expression |
ISO |
10 |
117,066,556 |
117,124,408 |
RGD:6480464 |
CTD |
| G |
Crebbp |
CREB binding protein |
|
multiple interactions |
ISO |
16 |
4,084,048 |
4,213,404 |
RGD:6480464 |
CTD |
| G |
Crispld2 |
cysteine-rich secretory protein LCCL domain containing 2 |
|
multiple interactions |
ISO |
8 |
122,516,370 |
122,576,693 |
RGD:6480464 |
CTD |
| G |
Crybb2 |
crystallin, beta B2 |
|
affects expression |
ISO |
5 |
113,487,285 |
113,497,786 |
RGD:6480464 |
CTD |
| G |
Csdc2 |
cold shock domain containing C2, RNA binding |
|
multiple interactions |
ISO |
15 |
81,767,189 |
81,781,371 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
ISO |
11 |
54,060,772 |
54,063,401 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
decreases expression |
ISO |
11 |
98,562,627 |
98,564,943 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
affects expression |
ISO |
14 |
63,741,302 |
63,764,758 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
9 |
89,949,105 |
89,970,933 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
affects expression |
EXP |
3 |
95,303,208 |
95,313,284 |
RGD:6480464 |
CTD |
| G |
Cuedc1 |
CUE domain containing 1 |
|
multiple interactions |
ISO |
11 |
87,912,648 |
88,007,642 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
affects expression |
ISO |
16 |
78,301,936 |
78,360,030 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
5 |
92,775,667 |
92,777,880 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
6 |
117,118,553 |
117,131,386 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
multiple interactions |
EXP |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
affects expression |
ISO |
1 |
92,100,578 |
92,112,863 |
RGD:6480464 |
CTD |
| G |
Cxcr7 |
chemokine (C-X-C motif) receptor 7 |
|
multiple interactions |
ISO |
1 |
92,100,578 |
92,112,863 |
RGD:6480464 |
CTD |
| G |
Cylc2 |
cylicin, basic protein of sperm head cytoskeleton 2 |
|
increases expression |
ISO |
4 |
51,229,550 |
51,242,800 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
54,013,744 |
54,041,249 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
9 |
57,535,735 |
57,551,629 |
RGD:6480464 |
CTD |
| G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
2 |
170,308,465 |
170,322,638 |
RGD:6480464 |
CTD |
| G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
6 |
84,521,408 |
84,543,902 |
RGD:6480464 |
CTD |
| G |
Cyp27a1 |
cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
1 |
74,760,148 |
74,784,464 |
RGD:6480464 |
CTD |
| G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
10 |
126,485,302 |
126,490,062 |
RGD:6480464 |
CTD |
| G |
Cyp2a12 |
cytochrome P450, family 2, subfamily a, polypeptide 12 |
|
affects expression |
ISO |
7 |
27,814,109 |
27,821,837 |
RGD:6480464 |
CTD |
| G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
|
decreases activity |
ISO |
19 |
39,188,388 |
39,261,246 |
RGD:6480464 |
CTD |
| G |
Cyp3a41a |
cytochrome P450, family 3, subfamily a, polypeptide 41A |
|
decreases activity |
ISO |
5 |
146,505,624 |
146,531,712 |
RGD:6480464 |
CTD |
| G |
D17Wsu92e |
DNA segment, Chr 17, Wayne State University 92, expressed |
|
decreases expression |
ISO |
17 |
27,888,180 |
27,957,487 |
RGD:6480464 |
CTD |
| G |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
|
affects expression |
ISO |
12 |
106,692,186 |
106,726,651 |
RGD:6480464 |
CTD |
| G |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
|
multiple interactions |
ISO |
12 |
106,692,186 |
106,726,651 |
RGD:6480464 |
CTD |
| G |
Dact1 |
dapper homolog 1, antagonist of beta-catenin (xenopus) |
|
multiple interactions |
ISO |
12 |
72,410,871 |
72,421,094 |
RGD:6480464 |
CTD |
| G |
Dag1 |
dystroglycan 1 |
|
increases expression |
ISO |
9 |
108,108,289 |
108,166,067 |
RGD:6480464 |
CTD |
| G |
Daxx |
Fas death domain-associated protein |
|
affects expression |
ISO |
17 |
34,046,443 |
34,052,534 |
RGD:6480464 |
CTD |
| G |
Dbp |
D site albumin promoter binding protein |
|
increases expression |
ISO |
7 |
52,960,617 |
52,965,573 |
RGD:6480464 |
CTD |
| G |
Dcbld2 |
discoidin, CUB and LCCL domain containing 2 |
|
multiple interactions |
ISO |
16 |
58,408,648 |
58,469,858 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
affects expression |
ISO |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Ddx21 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21 |
|
decreases expression |
ISO |
10 |
62,042,995 |
62,065,046 |
RGD:6480464 |
CTD |
| G |
Ddx3y |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked |
|
decreases expression |
ISO |
Y |
597,158 |
623,056 |
RGD:6480464 |
CTD |
| G |
Ddx50 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
|
affects expression |
ISO |
10 |
62,078,771 |
62,113,946 |
RGD:6480464 |
CTD |
| G |
Dhcr24 |
24-dehydrocholesterol reductase |
|
decreases expression |
ISO |
4 |
106,233,643 |
106,261,718 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase member 2 |
|
multiple interactions |
ISO |
14 |
55,840,844 |
55,860,277 |
RGD:6480464 |
CTD |
| G |
Dhx9 |
DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
decreases expression |
ISO |
1 |
155,302,888 |
155,334,790 |
RGD:6480464 |
CTD |
| G |
Dicer1 |
dicer 1, ribonuclease type III |
|
decreases expression |
ISO |
12 |
105,925,952 |
105,990,162 |
RGD:6480464 |
CTD |
| G |
Dkk2 |
dickkopf homolog 2 (Xenopus laevis) |
|
decreases expression |
ISO |
3 |
131,748,256 |
131,843,268 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
ISO |
7 |
138,175,590 |
138,265,142 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
ISO |
7 |
138,175,590 |
138,265,142 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
decreases expression |
ISO |
4 |
40,669,501 |
40,684,186 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression |
ISO |
8 |
86,132,074 |
86,135,802 |
RGD:6480464 |
CTD |
| G |
Dnajb4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
increases expression |
ISO |
3 |
151,846,919 |
151,873,263 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
12 |
45,306,884 |
45,311,055 |
RGD:6480464 |
CTD |
| G |
Dnmbp |
dynamin binding protein |
|
affects expression |
ISO |
19 |
43,922,457 |
43,986,882 |
RGD:6480464 |
CTD |
| G |
Dock9 |
dedicator of cytokinesis 9 |
|
multiple interactions |
ISO |
14 |
121,941,261 |
122,196,956 |
RGD:6480464 |
CTD |
| G |
Drd5 |
dopamine receptor D5 |
|
increases expression |
ISO |
5 |
38,710,748 |
38,713,549 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
multiple interactions |
ISO |
2 |
127,161,895 |
127,164,113 |
RGD:6480464 |
CTD |
| G |
Dusp2 |
dual specificity phosphatase 2 |
|
decreases expression |
ISO |
2 |
127,161,895 |
127,164,113 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
decreases expression |
ISO |
8 |
35,870,664 |
35,882,948 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
multiple interactions |
ISO |
19 |
53,603,808 |
53,615,812 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
affects expression |
ISO |
10 |
98,725,865 |
98,730,123 |
RGD:6480464 |
CTD |
| G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
|
affects expression |
ISO |
8 |
106,941,574 |
106,966,947 |
RGD:6480464 |
CTD |
| G |
E2f2 |
E2F transcription factor 2 |
|
increases expression |
ISO |
4 |
135,728,309 |
135,751,972 |
RGD:6480464 |
CTD |
| G |
Eci1 |
enoyl-Coenzyme A delta isomerase 1 |
|
affects expression |
ISO |
17 |
24,563,628 |
24,576,261 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
multiple interactions |
ISO |
2 |
174,586,274 |
174,609,543 |
RGD:6480464 |
CTD |
| G |
Edn3 |
endothelin 3 |
|
affects expression |
ISO |
2 |
174,586,274 |
174,609,543 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
multiple interactions |
ISO |
8 |
80,186,928 |
80,248,351 |
RGD:6480464 |
CTD |
| G |
Efemp1 |
epidermal growth factor-containing fibulin-like extracellular matrix protein 1 |
|
affects expression |
ISO |
11 |
28,753,205 |
28,826,743 |
RGD:6480464 |
CTD |
| G |
EG545370 |
predicted gene, EG545370 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
affects expression |
ISO |
12 |
55,279,968 |
55,304,861 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
35,020,861 |
35,024,610 |
RGD:6480464 |
CTD |
| G |
Eif1 |
eukaryotic translation initiation factor 1 |
|
multiple interactions |
ISO |
11 |
100,181,308 |
100,183,410 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
decreases expression |
ISO |
12 |
79,963,059 |
79,987,997 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
decreases expression |
ISO |
12 |
112,776,312 |
112,784,964 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
decreases expression |
ISO |
11 |
69,730,214 |
69,735,460 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
multiple interactions |
ISO |
1 |
137,150,151 |
137,155,049 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
1 |
137,150,151 |
137,155,049 |
RGD:6480464 |
CTD |
| G |
Ell |
elongation factor RNA polymerase II |
|
increases expression |
ISO |
8 |
73,063,574 |
73,116,757 |
RGD:6480464 |
CTD |
| G |
Elovl5 |
ELOVL family member 5, elongation of long chain fatty acids (yeast) |
|
decreases expression |
ISO |
9 |
77,765,172 |
77,832,326 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
ISO |
6 |
135,312,949 |
135,333,191 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
ISO |
13 |
98,011,060 |
98,022,995 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
multiple interactions |
ISO |
13 |
98,011,060 |
98,022,995 |
RGD:6480464 |
CTD |
| G |
Endod1 |
endonuclease domain containing 1 |
|
multiple interactions |
ISO |
9 |
14,158,434 |
14,185,686 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma neuronal |
|
affects expression |
ISO |
6 |
124,710,073 |
124,719,527 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
affects expression |
ISO |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
multiple interactions |
ISO |
15 |
54,670,453 |
54,751,701 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
increases expression |
ISO |
2 |
25,251,394 |
25,256,843 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
affects expression |
ISO |
9 |
21,763,343 |
21,768,020 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases response to substance |
EXP |
11 |
98,273,798 |
98,299,030 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
affects expression |
ISO |
10 |
128,006,424 |
128,026,557 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases response to substance |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects response to substance |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects folding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases activity |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
increases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
EXP |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects response to substance |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases activity |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases expression |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
decreases activity |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
multiple interactions |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 (alpha) |
|
affects binding |
ISO |
10 |
5,342,780 |
5,734,495 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases activity |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
decreases activity |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
affects expression |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
EXP |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
increases response to substance |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (beta) |
|
multiple interactions |
ISO |
12 |
77,221,406 |
77,278,246 |
RGD:6480464 |
CTD |
| G |
Evi2a |
ecotropic viral integration site 2a |
|
multiple interactions |
ISO |
11 |
79,340,062 |
79,344,111 |
RGD:6480464 |
CTD |
| G |
F11 |
coagulation factor XI |
|
increases activity |
ISO |
8 |
46,326,524 |
46,347,385 |
RGD:6480464 |
CTD |
| G |
F12 |
coagulation factor XII (Hageman factor) |
|
increases activity |
ISO |
13 |
55,519,327 |
55,528,163 |
RGD:6480464 |
CTD |
| G |
F13a1 |
coagulation factor XIII, A1 subunit |
|
affects expression |
ISO |
13 |
36,959,047 |
37,142,113 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
13 |
96,371,744 |
96,388,388 |
RGD:6480464 |
CTD |
| G |
F8 |
coagulation factor VIII |
|
increases activity |
ISO |
X |
72,418,054 |
72,625,380 |
RGD:6480464 |
CTD |
| G |
F8 |
coagulation factor VIII |
|
increases expression |
ISO |
X |
72,418,054 |
72,625,380 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
EXP |
3 |
10,204,342 |
10,208,576 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
7 |
151,764,228 |
151,768,341 |
RGD:6480464 |
CTD |
| G |
Fam134b |
family with sequence similarity 134, member B |
|
multiple interactions |
ISO |
15 |
25,773,019 |
25,903,442 |
RGD:6480464 |
CTD |
| G |
Fam65b |
family with sequence similarity 65, member B |
|
multiple interactions |
ISO |
13 |
24,706,479 |
24,825,675 |
RGD:6480464 |
CTD |
| G |
Fap |
fibroblast activation protein |
|
affects expression |
ISO |
2 |
62,339,002 |
62,412,078 |
RGD:6480464 |
CTD |
| G |
Fgd6 |
FYVE, RhoGEF and PH domain containing 6 |
|
multiple interactions |
ISO |
10 |
93,498,746 |
93,608,084 |
RGD:6480464 |
CTD |
| G |
Fgf9 |
fibroblast growth factor 9 |
|
affects expression |
ISO |
14 |
58,691,523 |
58,731,557 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
7 |
137,305,965 |
137,410,322 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
multiple interactions |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
affects expression |
ISO |
1 |
43,179,919 |
43,220,806 |
RGD:6480464 |
CTD |
| G |
Fis1 |
fission 1 (mitochondrial outer membrane) homolog (yeast) |
|
increases expression |
ISO |
5 |
137,429,145 |
137,442,104 |
RGD:6480464 |
CTD |
| G |
Fis1 |
fission 1 (mitochondrial outer membrane) homolog (yeast) |
|
affects expression |
ISO |
5 |
137,429,145 |
137,442,104 |
RGD:6480464 |
CTD |
| G |
Fkbp3 |
FK506 binding protein 3 |
|
affects expression |
ISO |
12 |
66,163,419 |
66,174,925 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin, beta |
|
multiple interactions |
ISO |
14 |
8,650,471 |
8,784,102 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin, beta |
|
affects expression |
ISO |
14 |
8,650,471 |
8,784,102 |
RGD:6480464 |
CTD |
| G |
Flnb |
filamin, beta |
|
multiple interactions |
ISO |
14 |
8,650,471 |
8,784,102 |
RGD:6480464 |
CTD |
| G |
Flnc |
filamin C, gamma |
|
decreases expression |
ISO |
6 |
29,383,153 |
29,411,888 |
RGD:6480464 |
CTD |
| G |
Flrt1 |
fibronectin leucine rich transmembrane protein 1 |
|
affects expression |
ISO |
19 |
7,166,491 |
7,180,219 |
RGD:6480464 |
CTD |
| G |
Fmnl1 |
formin-like 1 |
|
affects expression |
ISO |
11 |
103,032,452 |
103,060,214 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
1 |
71,632,097 |
71,699,745 |
RGD:6480464 |
CTD |
| G |
Fosl2 |
fos-like antigen 2 |
|
multiple interactions |
ISO |
5 |
32,438,845 |
32,460,213 |
RGD:6480464 |
CTD |
| G |
Foxe1 |
forkhead box E1 |
|
affects expression |
ISO |
4 |
46,357,066 |
46,358,181 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
affects expression |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
affects expression |
ISO |
13 |
115,242,470 |
115,248,938 |
RGD:6480464 |
CTD |
| G |
Fst |
follistatin |
|
multiple interactions |
ISO |
13 |
115,242,470 |
115,248,938 |
RGD:6480464 |
CTD |
| G |
Fut9 |
fucosyltransferase 9 |
|
multiple interactions |
ISO |
4 |
25,536,480 |
25,727,150 |
RGD:6480464 |
CTD |
| G |
Fyttd1 |
forty-two-three domain containing 1 |
|
decreases expression |
ISO |
16 |
32,877,870 |
32,909,049 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled homolog 6 (Drosophila) |
|
affects expression |
ISO |
15 |
38,837,826 |
38,869,738 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1 switch gene 2 |
|
multiple interactions |
ISO |
1 |
195,098,354 |
195,099,382 |
RGD:6480464 |
CTD |
| G |
Gabarap |
gamma-aminobutyric acid receptor associated protein |
|
affects expression |
ISO |
11 |
69,804,872 |
69,808,451 |
RGD:6480464 |
CTD |
| G |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
|
multiple interactions |
ISO |
4 |
46,676,770 |
47,004,586 |
RGD:6480464 |
CTD |
| G |
Gabpa |
GA repeat binding protein, alpha |
|
increases expression |
ISO |
16 |
84,835,369 |
84,864,024 |
RGD:6480464 |
CTD |
| G |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 1 |
|
affects expression |
ISO |
5 |
71,142,286 |
71,233,856 |
RGD:6480464 |
CTD |
| G |
Gabrr1 |
gamma-aminobutyric acid (GABA) C receptor, subunit rho 1 |
|
multiple interactions |
ISO |
4 |
33,219,531 |
33,250,563 |
RGD:6480464 |
CTD |
| G |
Gabrr1 |
gamma-aminobutyric acid (GABA) C receptor, subunit rho 1 |
|
affects expression |
ISO |
4 |
33,219,531 |
33,250,563 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
multiple interactions |
ISO |
2 |
70,400,221 |
70,440,069 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin |
|
decreases expression |
ISO |
19 |
3,409,917 |
3,414,457 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
affects expression |
ISO |
8 |
13,465,374 |
13,494,535 |
RGD:6480464 |
CTD |
| G |
Gata2 |
GATA binding protein 2 |
|
increases expression |
ISO |
6 |
88,148,658 |
88,157,026 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
affects expression |
ISO |
19 |
17,400,631 |
17,431,157 |
RGD:6480464 |
CTD |
| G |
Gfra2 |
glial cell line derived neurotrophic factor family receptor alpha 2 |
|
increases expression |
ISO |
14 |
71,289,937 |
71,379,645 |
RGD:6480464 |
CTD |
| G |
Gh |
growth hormone |
|
multiple interactions |
ISO |
11 |
106,161,582 |
106,163,124 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
ISO |
15 |
3,267,760 |
3,533,230 |
RGD:6480464 |
CTD |
| G |
Ghrh |
growth hormone releasing hormone |
|
affects expression |
ISO |
2 |
157,155,232 |
157,172,391 |
RGD:6480464 |
CTD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
affects expression |
ISO |
6 |
55,326,289 |
55,338,524 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
EXP |
14 |
57,717,439 |
57,723,539 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta subunit |
|
affects expression |
ISO |
3 |
80,647,526 |
80,717,546 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin |
|
affects expression |
ISO |
13 |
75,977,334 |
75,987,599 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase (glutamine synthetase) |
|
affects expression |
ISO |
1 |
155,747,075 |
155,756,844 |
RGD:6480464 |
CTD |
| G |
Glyat |
glycine-N-acyltransferase |
|
affects expression |
ISO |
19 |
12,707,798 |
12,726,227 |
RGD:6480464 |
CTD |
| G |
Gm9069 |
predicted gene 9069 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta 1 |
|
affects expression |
ISO |
4 |
154,865,470 |
154,933,378 |
RGD:6480464 |
CTD |
| G |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
|
increases expression |
ISO |
3 |
32,482,450 |
32,515,457 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin releasing hormone 1 |
|
multiple interactions |
ISO |
14 |
68,363,286 |
68,367,493 |
RGD:6480464 |
CTD |
| G |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
|
decreases expression |
ISO |
12 |
103,708,120 |
103,736,117 |
RGD:6480464 |
CTD |
| G |
Gpc1 |
glypican 1 |
|
affects expression |
ISO |
1 |
94,728,263 |
94,756,773 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
increases expression |
ISO |
X |
49,625,603 |
49,967,151 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
multiple interactions |
ISO |
6 |
48,986,517 |
49,008,181 |
RGD:6480464 |
CTD |
| G |
Gpr125 |
G protein-coupled receptor 125 |
|
increases expression |
ISO |
5 |
50,351,190 |
50,450,235 |
RGD:6480464 |
CTD |
| G |
Gpr56 |
G protein-coupled receptor 56 |
|
affects expression |
ISO |
8 |
97,508,503 |
97,538,091 |
RGD:6480464 |
CTD |
| G |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
|
multiple interactions |
ISO |
11 |
114,712,846 |
114,733,931 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
affects expression |
ISO |
11 |
11,830,502 |
11,937,423 |
RGD:6480464 |
CTD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
multiple interactions |
ISO |
11 |
11,830,502 |
11,937,423 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
decreases expression |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Greb1 |
gene regulated by estrogen in breast cancer protein |
|
multiple interactions |
ISO |
12 |
16,677,421 |
16,807,692 |
RGD:6480464 |
CTD |
| G |
Grhl1 |
grainyhead-like 1 (Drosophila) |
|
decreases expression |
ISO |
12 |
25,257,152 |
25,302,256 |
RGD:6480464 |
CTD |
| G |
Grina |
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
affects expression |
ISO |
15 |
76,077,237 |
76,080,334 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
affects expression |
ISO |
19 |
60,965,652 |
61,168,459 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
multiple interactions |
ISO |
19 |
60,965,652 |
61,168,459 |
RGD:6480464 |
CTD |
| G |
Gyg |
glycogenin |
|
multiple interactions |
ISO |
3 |
20,021,970 |
20,054,995 |
RGD:6480464 |
CTD |
| G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
affects expression |
ISO |
17 |
34,400,172 |
34,406,363 |
RGD:6480464 |
CTD |
| G |
H2afy |
H2A histone family, member Y |
|
affects expression |
ISO |
13 |
56,174,983 |
56,236,911 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
affects expression |
ISO |
10 |
92,951,513 |
92,979,488 |
RGD:6480464 |
CTD |
| G |
Hapln1 |
hyaluronan and proteoglycan link protein 1 |
|
affects expression |
ISO |
13 |
89,680,241 |
89,751,437 |
RGD:6480464 |
CTD |
| G |
Has2 |
hyaluronan synthase 2 |
|
multiple interactions |
ISO |
15 |
56,497,182 |
56,526,101 |
RGD:6480464 |
CTD |
| G |
Hba-a1 |
hemoglobin alpha, adult chain 1 |
|
affects expression |
ISO |
11 |
32,183,672 |
32,184,486 |
RGD:6480464 |
CTD |
| G |
Hbb-bh1 |
hemoglobin Z, beta-like embryonic chain |
|
affects expression |
ISO |
7 |
110,990,152 |
110,991,676 |
RGD:6480464 |
CTD |
| G |
Hbegf |
heparin-binding EGF-like growth factor |
|
multiple interactions |
ISO |
18 |
36,664,581 |
36,675,459 |
RGD:6480464 |
CTD |
| G |
Hbp1 |
high mobility group box transcription factor 1 |
|
increases expression |
ISO |
12 |
32,611,320 |
32,635,400 |
RGD:6480464 |
CTD |
| G |
Heg1 |
HEG homolog 1 (zebrafish) |
|
affects expression |
ISO |
16 |
33,684,552 |
33,768,281 |
RGD:6480464 |
CTD |
| G |
Heg1 |
HEG homolog 1 (zebrafish) |
|
multiple interactions |
ISO |
16 |
33,684,552 |
33,768,281 |
RGD:6480464 |
CTD |
| G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
increases expression |
ISO |
8 |
96,910,400 |
96,919,258 |
RGD:6480464 |
CTD |
| G |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
multiple interactions |
ISO |
10 |
30,552,165 |
30,562,589 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
ISO |
5 |
16,059,368 |
16,125,257 |
RGD:6480464 |
CTD |
| G |
Hist1h2af |
histone cluster 1, H2af |
|
affects expression |
ISO |
13 |
23,625,780 |
23,626,172 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
multiple interactions |
ISO |
10 |
61,731,603 |
61,842,656 |
RGD:6480464 |
CTD |
| G |
Hmga2 |
high mobility group AT-hook 2 |
|
affects expression |
ISO |
10 |
119,798,331 |
119,913,991 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
decreases expression |
ISO |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
affects expression |
ISO |
5 |
149,858,803 |
149,864,613 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
decreases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
affects expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression |
ISO |
6 |
51,410,433 |
51,419,893 |
RGD:6480464 |
CTD |
| G |
Hnrnph1 |
heterogeneous nuclear ribonucleoprotein H1 |
|
decreases expression |
ISO |
11 |
50,191,221 |
50,200,030 |
RGD:6480464 |
CTD |
| G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
|
decreases expression |
ISO |
1 |
180,258,431 |
180,267,915 |
RGD:6480464 |
CTD |
| G |
Homer2 |
homer homolog 2 (Drosophila) |
|
affects expression |
ISO |
7 |
88,745,367 |
88,851,811 |
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeobox A1 |
|
affects expression |
ISO |
6 |
52,105,366 |
52,108,316 |
RGD:6480464 |
CTD |
| G |
Hpcal1 |
hippocalcin-like 1 |
|
multiple interactions |
ISO |
12 |
17,697,620 |
17,798,732 |
RGD:6480464 |
CTD |
| G |
Hsd17b4 |
hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression |
ISO |
18 |
50,287,986 |
50,355,920 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
decreases expression |
ISO |
17 |
45,704,727 |
45,710,210 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta (Grp94), member 1 |
|
decreases expression |
ISO |
10 |
86,153,586 |
86,168,189 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
affects expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
decreases expression |
ISO |
11 |
53,073,316 |
53,113,981 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
decreases expression |
ISO |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein 8 |
|
multiple interactions |
ISO |
5 |
116,858,504 |
116,872,873 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases expression |
ISO |
1 |
55,134,678 |
55,144,776 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
affects expression |
ISO |
1 |
55,134,678 |
55,144,776 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
|
multiple interactions |
ISO |
14 |
75,040,647 |
75,106,666 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
|
affects expression |
ISO |
14 |
75,040,647 |
75,106,666 |
RGD:6480464 |
CTD |
| G |
Htr3a |
5-hydroxytryptamine (serotonin) receptor 3A |
|
multiple interactions |
ISO |
9 |
48,707,318 |
48,719,204 |
RGD:6480464 |
CTD |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A |
|
affects expression |
ISO |
5 |
28,168,487 |
28,181,626 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
affects expression |
ISO |
2 |
152,562,010 |
152,563,146 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
multiple interactions |
ISO |
13 |
48,356,796 |
48,359,405 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
ISO |
7 |
87,239,732 |
87,260,236 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
affects expression |
ISO |
7 |
87,239,732 |
87,260,236 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
ISO |
7 |
87,239,732 |
87,260,236 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
affects expression |
ISO |
7 |
87,239,732 |
87,260,236 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
multiple interactions |
ISO |
17 |
35,958,658 |
35,959,856 |
RGD:6480464 |
CTD |
| G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
affects expression |
ISO |
19 |
34,625,184 |
34,651,024 |
RGD:6480464 |
CTD |
| G |
Ifngr2 |
interferon gamma receptor 2 |
|
multiple interactions |
ISO |
16 |
91,547,339 |
91,564,252 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
decreases expression |
ISO |
12 |
40,929,716 |
40,949,776 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
increases expression |
ISO |
7 |
149,836,673 |
149,846,940 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
increases expression |
ISO |
11 |
7,106,089 |
7,113,926 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
affects expression |
ISO |
11 |
98,902,574 |
98,913,960 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
15 |
101,974,617 |
101,979,943 |
RGD:6480464 |
CTD |
| G |
Il10ra |
interleukin 10 receptor, alpha |
|
increases expression |
ISO |
9 |
45,061,922 |
45,077,229 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12a |
|
decreases expression |
ISO |
3 |
68,494,566 |
68,502,469 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
affects expression |
ISO |
16 |
26,581,791 |
26,725,233 |
RGD:6480464 |
CTD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
affects expression |
ISO |
7 |
132,695,796 |
132,722,988 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il7r |
interleukin 7 receptor |
|
affects expression |
ISO |
15 |
9,435,914 |
9,459,631 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
ISO |
13 |
16,106,308 |
16,119,044 |
RGD:6480464 |
CTD |
| G |
Inpp4b |
inositol polyphosphate-4-phosphatase, type II |
|
affects expression |
ISO |
8 |
84,239,099 |
84,646,460 |
RGD:6480464 |
CTD |
| G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
multiple interactions |
ISO |
7 |
146,575,008 |
146,765,551 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
increases expression |
ISO |
5 |
28,397,952 |
28,405,202 |
RGD:6480464 |
CTD |
| G |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
|
decreases expression |
ISO |
7 |
87,856,469 |
87,948,217 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
affects expression |
ISO |
7 |
148,449,088 |
148,452,300 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon-stimulated protein |
|
affects expression |
ISO |
7 |
86,058,651 |
86,065,282 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon-stimulated protein |
|
multiple interactions |
ISO |
7 |
86,058,651 |
86,065,282 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
|
increases expression |
ISO |
8 |
131,209,554 |
131,257,479 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin beta 1 (fibronectin receptor beta) |
|
increases expression |
ISO |
8 |
131,209,554 |
131,257,479 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-triphosphate receptor 3 |
|
affects expression |
ISO |
17 |
27,194,249 |
27,259,168 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
affects expression |
ISO |
3 |
92,374,824 |
92,377,637 |
RGD:6480464 |
CTD |
| G |
Ivl |
involucrin |
|
multiple interactions |
ISO |
3 |
92,374,824 |
92,377,637 |
RGD:6480464 |
CTD |
| G |
Jag1 |
jagged 1 |
|
multiple interactions |
ISO |
2 |
136,907,194 |
136,942,067 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
multiple interactions |
ISO |
19 |
29,326,318 |
29,387,570 |
RGD:6480464 |
CTD |
| G |
Kcne1 |
potassium voltage-gated channel, Isk-related subfamily, member 1 |
|
increases expression |
ISO |
16 |
92,346,246 |
92,359,713 |
RGD:6480464 |
CTD |
| G |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
|
affects expression |
ISO |
12 |
75,998,204 |
76,278,319 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
affects expression |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
multiple interactions |
ISO |
7 |
25,155,282 |
25,170,231 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
affects expression |
ISO |
14 |
103,375,798 |
103,381,854 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
multiple interactions |
ISO |
14 |
103,375,798 |
103,381,854 |
RGD:6480464 |
CTD |
| G |
Kif20a |
kinesin family member 20A |
|
decreases expression |
ISO |
18 |
34,784,278 |
34,792,931 |
RGD:6480464 |
CTD |
| G |
Kif3c |
kinesin family member 3C |
|
multiple interactions |
ISO |
12 |
3,365,132 |
3,406,494 |
RGD:6480464 |
CTD |
| G |
Klf10 |
Kruppel-like factor 10 |
|
affects expression |
ISO |
15 |
38,224,168 |
38,230,462 |
RGD:6480464 |
CTD |
| G |
Klf6 |
Kruppel-like factor 6 |
|
decreases expression |
ISO |
13 |
5,860,735 |
5,869,639 |
RGD:6480464 |
CTD |
| G |
Klhl24 |
kelch-like 24 |
|
increases expression |
ISO |
16 |
20,097,627 |
20,127,817 |
RGD:6480464 |
CTD |
| G |
Klrc1 |
killer cell lectin-like receptor subfamily C, member 1 |
|
increases expression |
ISO |
6 |
129,624,877 |
129,628,928 |
RGD:6480464 |
CTD |
| G |
Klrc2 |
killer cell lectin-like receptor subfamily C, member 2 |
|
multiple interactions |
ISO |
6 |
129,606,364 |
129,610,614 |
RGD:6480464 |
CTD |
| G |
Klrc2 |
killer cell lectin-like receptor subfamily C, member 2 |
|
affects expression |
ISO |
6 |
129,606,364 |
129,610,614 |
RGD:6480464 |
CTD |
| G |
Klrc2 |
killer cell lectin-like receptor subfamily C, member 2 |
|
multiple interactions |
ISO |
6 |
129,606,364 |
129,610,614 |
RGD:6480464 |
CTD |
| G |
Klrc3 |
killer cell lectin-like receptor subfamily C, member 3 |
|
multiple interactions |
ISO |
6 |
129,589,103 |
129,593,306 |
RGD:6480464 |
CTD |
| G |
Klrc3 |
killer cell lectin-like receptor subfamily C, member 3 |
|
multiple interactions |
ISO |
6 |
129,589,103 |
129,593,306 |
RGD:6480464 |
CTD |
| G |
Klrc3 |
killer cell lectin-like receptor subfamily C, member 3 |
|
increases expression |
ISO |
6 |
129,589,103 |
129,593,306 |
RGD:6480464 |
CTD |
| G |
Klrk1 |
killer cell lectin-like receptor subfamily K, member 1 |
|
multiple interactions |
ISO |
6 |
129,560,339 |
129,573,859 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin (importin) alpha 2 |
|
decreases expression |
ISO |
11 |
106,849,943 |
106,860,839 |
RGD:6480464 |
CTD |
| G |
Kpnb1 |
karyopherin (importin) beta 1 |
|
decreases expression |
ISO |
11 |
97,021,024 |
97,049,206 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
ISO |
11 |
100,117,531 |
100,122,303 |
RGD:6480464 |
CTD |
| G |
Krt34 |
keratin 34 |
|
multiple interactions |
ISO |
11 |
99,898,665 |
99,902,868 |
RGD:6480464 |
CTD |
| G |
L3mbtl1 |
l(3)mbt-like (Drosophila) |
|
decreases expression |
ISO |
2 |
162,769,201 |
162,800,258 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
affects expression |
ISO |
1 |
155,066,052 |
155,179,916 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb-bud and heart |
|
multiple interactions |
ISO |
17 |
73,267,645 |
73,291,286 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
affects expression |
ISO |
2 |
32,240,157 |
32,243,259 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
increases expression |
ISO |
9 |
21,528,038 |
21,554,363 |
RGD:6480464 |
CTD |
| G |
Ldlrad4 |
low density lipoprotein receptor class A domain containing 4 |
|
multiple interactions |
ISO |
18 |
68,092,911 |
68,415,203 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
multiple interactions |
ISO |
7 |
52,673,729 |
52,675,734 |
RGD:6480464 |
CTD |
| G |
Lmcd1 |
LIM and cysteine-rich domains 1 |
|
multiple interactions |
ISO |
6 |
112,223,752 |
112,280,417 |
RGD:6480464 |
CTD |
| G |
Lmnb2 |
lamin B2 |
|
multiple interactions |
ISO |
10 |
80,364,108 |
80,380,990 |
RGD:6480464 |
CTD |
| G |
Lmnb2 |
lamin B2 |
|
affects expression |
ISO |
10 |
80,364,108 |
80,380,990 |
RGD:6480464 |
CTD |
| G |
Lox |
lysyl oxidase |
|
affects expression |
ISO |
18 |
52,676,892 |
52,689,362 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
multiple interactions |
ISO |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lpl |
lipoprotein lipase |
|
increases expression |
EXP |
8 |
71,404,454 |
71,430,831 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression |
ISO |
6 |
94,554,523 |
94,650,139 |
RGD:6480464 |
CTD |
| G |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
|
multiple interactions |
ISO |
6 |
94,554,523 |
94,650,139 |
RGD:6480464 |
CTD |
| G |
Lrrc20 |
leucine rich repeat containing 20 |
|
multiple interactions |
ISO |
10 |
60,938,581 |
61,044,990 |
RGD:6480464 |
CTD |
| G |
Ltb |
lymphotoxin B |
|
decreases expression |
ISO |
17 |
35,331,452 |
35,333,250 |
RGD:6480464 |
CTD |
| G |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
|
affects expression |
ISO |
17 |
75,404,869 |
75,791,109 |
RGD:6480464 |
CTD |
| G |
Lum |
lumican |
|
affects expression |
ISO |
10 |
97,028,135 |
97,035,337 |
RGD:6480464 |
CTD |
| G |
Ly6i |
lymphocyte antigen 6 complex, locus I |
|
affects expression |
ISO |
15 |
74,810,242 |
74,813,860 |
RGD:6480464 |
CTD |
| G |
Lysmd4 |
LysM, putative peptidoglycan-binding, domain containing 4 |
|
multiple interactions |
ISO |
7 |
74,367,494 |
74,373,342 |
RGD:6480464 |
CTD |
| G |
Maf |
avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog |
|
increases expression |
ISO |
8 |
118,227,153 |
118,230,794 |
RGD:6480464 |
CTD |
| G |
Maff |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) |
|
multiple interactions |
ISO |
15 |
79,178,108 |
79,189,506 |
RGD:6480464 |
CTD |
| G |
Man2a2 |
mannosidase 2, alpha 2 |
|
affects expression |
ISO |
7 |
87,505,336 |
87,516,012 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen-activated protein kinase kinase 3 |
|
multiple interactions |
ISO |
11 |
60,745,559 |
60,766,305 |
RGD:6480464 |
CTD |
| G |
Map2k6 |
mitogen-activated protein kinase kinase 6 |
|
multiple interactions |
ISO |
11 |
110,260,436 |
110,374,951 |
RGD:6480464 |
CTD |
| G |
Map3k11 |
mitogen-activated protein kinase kinase kinase 11 |
|
increases expression |
ISO |
19 |
5,689,131 |
5,702,865 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
10 |
19,654,332 |
19,862,556 |
RGD:6480464 |
CTD |
| G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions |
ISO |
18 |
4,331,325 |
4,352,951 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
affects expression |
ISO |
17 |
28,828,287 |
28,885,350 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapkapk2 |
MAP kinase-activated protein kinase 2 |
|
multiple interactions |
ISO |
1 |
132,950,281 |
132,994,120 |
RGD:6480464 |
CTD |
| G |
Marcksl1 |
MARCKS-like 1 |
|
affects expression |
ISO |
4 |
129,190,825 |
129,193,225 |
RGD:6480464 |
CTD |
| G |
Matr3 |
matrin 3 |
|
decreases expression |
ISO |
18 |
35,721,812 |
35,751,699 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like 2 |
|
multiple interactions |
ISO |
14 |
120,674,891 |
120,830,920 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
affects expression |
ISO |
14 |
56,636,801 |
56,639,228 |
RGD:6480464 |
CTD |
| G |
Mcpt4 |
mast cell protease 4 |
|
affects expression |
ISO |
14 |
56,678,581 |
56,681,147 |
RGD:6480464 |
CTD |
| G |
Mdfic |
MyoD family inhibitor domain containing |
|
affects expression |
ISO |
6 |
15,670,661 |
15,752,169 |
RGD:6480464 |
CTD |
| G |
Mdfic |
MyoD family inhibitor domain containing |
|
multiple interactions |
ISO |
6 |
15,670,661 |
15,752,169 |
RGD:6480464 |
CTD |
| G |
Mef2a |
myocyte enhancer factor 2A |
|
multiple interactions |
ISO |
7 |
74,378,710 |
74,517,744 |
RGD:6480464 |
CTD |
| G |
Mettl7a1 |
methyltransferase like 7A1 |
|
multiple interactions |
ISO |
15 |
100,135,248 |
100,144,779 |
RGD:6480464 |
CTD |
| G |
Mettl7a1 |
methyltransferase like 7A1 |
|
affects expression |
ISO |
15 |
100,135,248 |
100,144,779 |
RGD:6480464 |
CTD |
| G |
Mfap5 |
microfibrillar associated protein 5 |
|
multiple interactions |
ISO |
6 |
122,463,694 |
122,479,308 |
RGD:6480464 |
CTD |
| G |
Mfap5 |
microfibrillar associated protein 5 |
|
affects expression |
ISO |
6 |
122,463,694 |
122,479,308 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
decreases expression |
ISO |
6 |
136,820,956 |
136,824,326 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
|
decreases expression |
ISO |
7 |
142,881,471 |
142,908,062 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
affects expression |
ISO |
9 |
7,347,374 |
7,360,461 |
RGD:6480464 |
CTD |
| G |
Mmp12 |
matrix metallopeptidase 12 |
|
multiple interactions |
ISO |
9 |
7,347,374 |
7,360,461 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
affects expression |
ISO |
8 |
95,351,227 |
95,377,319 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases expression |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
decreases activity |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mn1 |
meningioma 1 |
|
multiple interactions |
ISO |
5 |
111,847,186 |
111,886,045 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
11 |
87,607,286 |
87,617,914 |
RGD:6480464 |
CTD |
| G |
Mr1 |
major histocompatibility complex, class I-related |
|
increases expression |
ISO |
1 |
156,975,008 |
156,993,910 |
RGD:6480464 |
CTD |
| G |
Mrpl33 |
mitochondrial ribosomal protein L33 |
|
affects expression |
ISO |
5 |
31,916,324 |
31,925,017 |
RGD:6480464 |
CTD |
| G |
Msmb |
beta-microseminoprotein |
|
multiple interactions |
ISO |
14 |
32,955,209 |
32,971,513 |
RGD:6480464 |
CTD |
| G |
Msmb |
beta-microseminoprotein |
|
affects expression |
ISO |
14 |
32,955,209 |
32,971,513 |
RGD:6480464 |
CTD |
| G |
Msmb |
beta-microseminoprotein |
|
multiple interactions |
ISO |
14 |
32,955,209 |
32,971,513 |
RGD:6480464 |
CTD |
| G |
Mst1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression |
ISO |
9 |
107,982,767 |
107,987,358 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mthfr |
5,10-methylenetetrahydrofolate reductase |
|
decreases expression |
ISO |
4 |
147,413,186 |
147,433,671 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, transmembrane |
|
increases expression |
ISO |
3 |
89,032,974 |
89,037,291 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, transmembrane |
|
affects expression |
ISO |
3 |
89,032,974 |
89,037,291 |
RGD:6480464 |
CTD |
| G |
Myb |
myeloblastosis oncogene |
|
multiple interactions |
ISO |
10 |
20,844,736 |
20,880,790 |
RGD:6480464 |
CTD |
| G |
Mybl1 |
myeloblastosis oncogene-like 1 |
|
multiple interactions |
ISO |
1 |
9,658,912 |
9,690,290 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
ISO |
15 |
61,816,896 |
61,821,916 |
RGD:6480464 |
CTD |
| G |
Myd116 |
myeloid differentiation primary response gene 116 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myd116 |
myeloid differentiation primary response gene 116 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Myl9 |
myosin, light polypeptide 9, regulatory |
|
affects expression |
ISO |
2 |
156,601,200 |
156,607,393 |
RGD:6480464 |
CTD |
| G |
Myo10 |
myosin X |
|
affects expression |
ISO |
15 |
25,552,305 |
25,743,426 |
RGD:6480464 |
CTD |
| G |
Myod1 |
myogenic differentiation 1 |
|
decreases expression |
ISO |
7 |
53,631,844 |
53,634,462 |
RGD:6480464 |
CTD |
| G |
Myt1l |
myelin transcription factor 1-like |
|
multiple interactions |
ISO |
12 |
30,213,249 |
30,608,074 |
RGD:6480464 |
CTD |
| G |
Nab1 |
Ngfi-A binding protein 1 |
|
multiple interactions |
ISO |
1 |
52,512,693 |
52,557,292 |
RGD:6480464 |
CTD |
| G |
Nars |
asparaginyl-tRNA synthetase |
|
decreases expression |
ISO |
18 |
64,659,301 |
64,676,211 |
RGD:6480464 |
CTD |
| G |
Nav2 |
neuron navigator 2 |
|
multiple interactions |
ISO |
7 |
56,214,443 |
56,865,458 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma, suppression of tumorigenicity 1 |
|
increases expression |
ISO |
4 |
138,638,207 |
138,648,885 |
RGD:6480464 |
CTD |
| G |
Ncaph |
non-SMC condensin I complex, subunit H |
|
decreases expression |
ISO |
2 |
126,929,545 |
126,959,690 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
1 |
154,655,020 |
154,684,120 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
affects expression |
ISO |
1 |
154,655,020 |
154,684,120 |
RGD:6480464 |
CTD |
| G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
1 |
154,655,020 |
154,684,120 |
RGD:6480464 |
CTD |
| G |
Ncl |
nucleolin |
|
decreases expression |
ISO |
1 |
88,241,294 |
88,256,030 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
increases expression |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
12 |
4,247,362 |
4,484,060 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
increases expression |
ISO |
1 |
13,129,240 |
13,364,164 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
multiple interactions |
ISO |
2 |
165,818,137 |
165,898,742 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
multiple interactions |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ncor2 |
nuclear receptor co-repressor 2 |
|
decreases expression |
ISO |
5 |
125,497,525 |
125,659,584 |
RGD:6480464 |
CTD |
| G |
Ndrg4 |
N-myc downstream regulated gene 4 |
|
multiple interactions |
ISO |
8 |
98,226,963 |
98,238,856 |
RGD:6480464 |
CTD |
| G |
Ndufa2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 |
|
affects expression |
ISO |
18 |
36,902,020 |
36,904,202 |
RGD:6480464 |
CTD |
| G |
Nefl |
neurofilament, light polypeptide |
|
affects expression |
ISO |
14 |
68,701,941 |
68,705,802 |
RGD:6480464 |
CTD |
| G |
Nek7 |
NIMA (never in mitosis gene a)-related expressed kinase 7 |
|
affects expression |
ISO |
1 |
140,381,291 |
140,516,273 |
RGD:6480464 |
CTD |
| G |
Nf1 |
neurofibromatosis 1 |
|
increases expression |
ISO |
11 |
79,153,394 |
79,395,111 |
RGD:6480464 |
CTD |
| G |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
|
increases expression |
ISO |
11 |
96,678,728 |
96,691,282 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3, regulated |
|
affects expression |
ISO |
13 |
53,062,578 |
53,076,408 |
RGD:6480464 |
CTD |
| G |
Nfil3 |
nuclear factor, interleukin 3, regulated |
|
multiple interactions |
ISO |
13 |
53,062,578 |
53,076,408 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
affects expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
decreases expression |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbie |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon |
|
multiple interactions |
ISO |
17 |
45,692,665 |
45,700,118 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
multiple interactions |
ISO |
13 |
49,282,916 |
49,291,620 |
RGD:6480464 |
CTD |
| G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
|
multiple interactions |
ISO |
11 |
59,356,188 |
59,380,458 |
RGD:6480464 |
CTD |
| G |
Nme6 |
NME/NM23 nucleoside diphosphate kinase 6 |
|
affects expression |
ISO |
9 |
109,735,308 |
109,745,475 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases expression |
ISO |
11 |
78,734,361 |
78,773,626 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
increases expression |
ISO |
5 |
23,870,637 |
23,890,292 |
RGD:6480464 |
CTD |
| G |
Notch3 |
notch 3 |
|
affects expression |
ISO |
17 |
32,257,838 |
32,303,797 |
RGD:6480464 |
CTD |
| G |
Nov |
nephroblastoma overexpressed gene |
|
multiple interactions |
ISO |
15 |
54,577,483 |
54,585,317 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin 1 |
|
decreases expression |
ISO |
11 |
33,052,511 |
33,063,056 |
RGD:6480464 |
CTD |
| G |
Npr2 |
natriuretic peptide receptor 2 |
|
affects expression |
ISO |
4 |
43,644,807 |
43,664,116 |
RGD:6480464 |
CTD |
| G |
Npr2 |
natriuretic peptide receptor 2 |
|
multiple interactions |
ISO |
4 |
43,644,807 |
43,664,116 |
RGD:6480464 |
CTD |
| G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
|
multiple interactions |
ISO |
11 |
98,629,249 |
98,636,556 |
RGD:6480464 |
CTD |
| G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
|
affects expression |
ISO |
8 |
73,898,018 |
73,905,851 |
RGD:6480464 |
CTD |
| G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
|
multiple interactions |
ISO |
8 |
73,898,018 |
73,905,851 |
RGD:6480464 |
CTD |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions |
ISO |
18 |
39,570,199 |
39,646,899 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
increases expression |
ISO |
15 |
101,097,277 |
101,105,226 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
ISO |
4 |
48,064,120 |
48,096,224 |
RGD:6480464 |
CTD |
| G |
Nrep |
neuronal regeneration related protein |
|
affects expression |
ISO |
18 |
33,596,673 |
33,623,683 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
increases expression |
ISO |
6 |
29,997,988 |
30,103,458 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
multiple interactions |
ISO |
6 |
29,997,988 |
30,103,458 |
RGD:6480464 |
CTD |
| G |
Nrg2 |
neuregulin 2 |
|
increases expression |
ISO |
18 |
36,177,303 |
36,356,814 |
RGD:6480464 |
CTD |
| G |
Nuak1 |
NUAK family, SNF1-like kinase, 1 |
|
affects expression |
ISO |
10 |
83,834,056 |
83,903,216 |
RGD:6480464 |
CTD |
| G |
Nuak1 |
NUAK family, SNF1-like kinase, 1 |
|
multiple interactions |
ISO |
10 |
83,834,056 |
83,903,216 |
RGD:6480464 |
CTD |
| G |
Nup160 |
nucleoporin 160 |
|
increases expression |
ISO |
2 |
90,517,372 |
90,576,485 |
RGD:6480464 |
CTD |
| G |
Nus1 |
nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
10 |
52,137,353 |
52,159,998 |
RGD:6480464 |
CTD |
| G |
Nxf1 |
nuclear RNA export factor 1 |
|
affects expression |
ISO |
19 |
8,831,593 |
8,845,400 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
13 |
101,267,322 |
101,322,453 |
RGD:6480464 |
CTD |
| G |
Olfml2a |
olfactomedin-like 2A |
|
affects expression |
ISO |
2 |
38,787,500 |
38,816,105 |
RGD:6480464 |
CTD |
| G |
Olfr122 |
olfactory receptor 122 |
|
affects expression |
ISO |
17 |
37,908,573 |
37,909,565 |
RGD:6480464 |
CTD |
| G |
Osbpl3 |
oxysterol binding protein-like 3 |
|
multiple interactions |
ISO |
6 |
50,243,326 |
50,406,169 |
RGD:6480464 |
CTD |
| G |
Osbpl7 |
oxysterol binding protein-like 7 |
|
increases expression |
ISO |
11 |
96,912,134 |
96,930,218 |
RGD:6480464 |
CTD |
| G |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
|
multiple interactions |
ISO |
12 |
104,615,104 |
104,644,560 |
RGD:6480464 |
CTD |
| G |
Palld |
palladin, cytoskeletal associated protein |
|
affects expression |
ISO |
8 |
63,993,818 |
64,381,487 |
RGD:6480464 |
CTD |
| G |
Papola |
poly (A) polymerase alpha |
|
affects expression |
ISO |
12 |
107,022,912 |
107,077,154 |
RGD:6480464 |
CTD |
| G |
Pappa |
pregnancy-associated plasma protein A |
|
increases expression |
ISO |
4 |
64,785,208 |
65,018,543 |
RGD:6480464 |
CTD |
| G |
Pawr |
PRKC, apoptosis, WT1, regulator |
|
increases expression |
ISO |
10 |
107,769,245 |
107,851,447 |
RGD:6480464 |
CTD |
| G |
Pax5 |
paired box gene 5 |
|
increases expression |
ISO |
4 |
44,544,378 |
44,723,312 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
multiple interactions |
ISO |
5 |
58,109,260 |
58,523,479 |
RGD:6480464 |
CTD |
| G |
Pcdhga3 |
protocadherin gamma subfamily A, 3 |
|
increases expression |
ISO |
18 |
37,833,989 |
38,001,527 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
affects expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer protein |
|
affects expression |
ISO |
5 |
138,046,335 |
138,052,632 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer protein |
|
increases expression |
ISO |
5 |
138,046,335 |
138,052,632 |
RGD:6480464 |
CTD |
| G |
Pctp |
phosphatidylcholine transfer protein |
|
multiple interactions |
ISO |
11 |
89,844,731 |
89,864,208 |
RGD:6480464 |
CTD |
| G |
Pdcd5 |
programmed cell death 5 |
|
increases expression |
ISO |
7 |
36,427,004 |
36,432,501 |
RGD:6480464 |
CTD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
increases expression |
ISO |
7 |
121,558,768 |
121,681,451 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP specific |
|
increases expression |
ISO |
13 |
109,444,371 |
110,741,682 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
decreases expression |
ISO |
3 |
122,432,076 |
122,562,292 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
affects expression |
ISO |
5 |
75,548,316 |
75,594,229 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
affects expression |
ISO |
18 |
61,204,804 |
61,244,721 |
RGD:6480464 |
CTD |
| G |
Pdlim3 |
PDZ and LIM domain 3 |
|
multiple interactions |
ISO |
8 |
46,970,839 |
47,004,900 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
multiple interactions |
ISO |
4 |
11,885,332 |
11,893,597 |
RGD:6480464 |
CTD |
| G |
Pdyn |
prodynorphin |
|
affects expression |
ISO |
2 |
129,513,737 |
129,515,604 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
multiple interactions |
ISO |
2 |
11,393,057 |
11,475,556 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
decreases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
9 |
8,899,833 |
8,968,611 |
RGD:6480464 |
CTD |
| G |
Phc2 |
polyhomeotic-like 2 (Drosophila) |
|
multiple interactions |
ISO |
4 |
128,382,240 |
128,430,118 |
RGD:6480464 |
CTD |
| G |
Phf11c |
PHD finger protein 11C |
|
multiple interactions |
ISO |
14 |
59,999,670 |
60,012,349 |
RGD:6480464 |
CTD |
| G |
Phf11d |
PHD finger protein 11D |
|
multiple interactions |
ISO |
14 |
59,966,244 |
59,984,327 |
RGD:6480464 |
CTD |
| G |
Pias3 |
protein inhibitor of activated STAT 3 |
|
affects expression |
ISO |
3 |
96,500,298 |
96,509,993 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
affects expression |
ISO |
1 |
132,723,261 |
132,748,826 |
RGD:6480464 |
CTD |
| G |
Pim1 |
proviral integration site 1 |
|
affects expression |
ISO |
17 |
29,627,990 |
29,632,410 |
RGD:6480464 |
CTD |
| G |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
|
multiple interactions |
ISO |
11 |
107,069,206 |
107,332,034 |
RGD:6480464 |
CTD |
| G |
Pla2g7 |
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
decreases expression |
ISO |
17 |
43,705,400 |
43,749,150 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
increases expression |
ISO |
8 |
23,868,216 |
23,893,320 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
decreases expression |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plau |
plasminogen activator, urokinase |
|
multiple interactions |
ISO |
14 |
21,655,884 |
21,662,610 |
RGD:6480464 |
CTD |
| G |
Plaur |
plasminogen activator, urokinase receptor |
|
decreases expression |
ISO |
7 |
25,247,519 |
25,260,892 |
RGD:6480464 |
CTD |
| G |
Plk3 |
polo-like kinase 3 |
|
multiple interactions |
EXP |
4 |
116,801,260 |
116,806,557 |
RGD:6480464 |
CTD |
| G |
Plxnd1 |
plexin D1 |
|
increases expression |
ISO |
6 |
115,904,829 |
115,945,023 |
RGD:6480464 |
CTD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression |
ISO |
18 |
66,618,258 |
66,625,212 |
RGD:6480464 |
CTD |
| G |
Pms2 |
postmeiotic segregation increased 2 (S. cerevisiae) |
|
increases expression |
ISO |
5 |
144,670,870 |
144,692,625 |
RGD:6480464 |
CTD |
| G |
Podxl |
podocalyxin-like |
|
affects expression |
ISO |
6 |
31,469,493 |
31,513,937 |
RGD:6480464 |
CTD |
| G |
Polm |
polymerase (DNA directed), mu |
|
increases expression |
ISO |
11 |
5,727,863 |
5,738,019 |
RGD:6480464 |
CTD |
| G |
Polr2b |
polymerase (RNA) II (DNA directed) polypeptide B |
|
decreases expression |
ISO |
5 |
77,739,509 |
77,778,353 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
affects expression |
ISO |
13 |
113,591,000 |
113,657,888 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
multiple interactions |
ISO |
4 |
104,829,952 |
104,905,372 |
RGD:6480464 |
CTD |
| G |
Ppap2b |
phosphatidic acid phosphatase type 2B |
|
affects expression |
ISO |
4 |
104,829,952 |
104,905,372 |
RGD:6480464 |
CTD |
| G |
Ppm1d |
protein phosphatase 1D magnesium-dependent, delta isoform |
|
decreases expression |
ISO |
11 |
85,124,756 |
85,160,573 |
RGD:6480464 |
CTD |
| G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
|
increases expression |
ISO |
17 |
36,053,856 |
36,069,228 |
RGD:6480464 |
CTD |
| G |
Ppp1r13b |
protein phosphatase 1, regulatory (inhibitor) subunit 13B |
|
decreases expression |
ISO |
12 |
113,066,669 |
113,146,266 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
affects expression |
ISO |
8 |
87,493,547 |
87,498,212 |
RGD:6480464 |
CTD |
| G |
Prkcz |
protein kinase C, zeta |
|
multiple interactions |
ISO |
4 |
154,634,229 |
154,735,500 |
RGD:6480464 |
CTD |
| G |
Prkdc |
protein kinase, DNA activated, catalytic polypeptide |
|
decreases expression |
ISO |
16 |
15,637,959 |
15,842,332 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
decreases secretion |
ISO |
13 |
27,149,439 |
27,157,073 |
RGD:6480464 |
CTD |
| G |
Proc |
protein C |
|
decreases activity |
ISO |
18 |
32,282,780 |
32,299,224 |
RGD:6480464 |
CTD |
| G |
Pros1 |
protein S (alpha) |
|
affects expression |
ISO |
16 |
62,854,160 |
62,929,166 |
RGD:6480464 |
CTD |
| G |
Pros1 |
protein S (alpha) |
|
decreases expression |
ISO |
16 |
62,854,160 |
62,929,166 |
RGD:6480464 |
CTD |
| G |
Prpf4b |
PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
|
decreases expression |
ISO |
13 |
34,967,363 |
34,994,747 |
RGD:6480464 |
CTD |
| G |
Psap |
prosaposin |
|
affects expression |
ISO |
10 |
59,740,376 |
59,765,348 |
RGD:6480464 |
CTD |
| G |
Psmd14 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
decreases expression |
ISO |
2 |
61,549,751 |
61,638,433 |
RGD:6480464 |
CTD |
| G |
Psmd6 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
decreases expression |
ISO |
14 |
14,944,699 |
14,953,418 |
RGD:6480464 |
CTD |
| G |
Psme1 |
proteasome (prosome, macropain) 28 subunit, alpha |
|
affects expression |
ISO |
14 |
56,197,331 |
56,200,364 |
RGD:6480464 |
CTD |
| G |
Psme4 |
proteasome (prosome, macropain) activator subunit 4 |
|
decreases expression |
ISO |
11 |
30,671,775 |
30,780,361 |
RGD:6480464 |
CTD |
| G |
Ptgds |
prostaglandin D2 synthase (brain) |
|
multiple interactions |
EXP |
2 |
25,322,232 |
25,325,269 |
RGD:6480464 |
CTD |
| G |
Ptger3 |
prostaglandin E receptor 3 (subtype EP3) |
|
multiple interactions |
ISO |
3 |
157,229,856 |
157,307,722 |
RGD:6480464 |
CTD |
| G |
Ptges |
prostaglandin E synthase |
|
multiple interactions |
ISO |
2 |
30,744,991 |
30,758,817 |
RGD:6480464 |
CTD |
| G |
Ptgfrn |
prostaglandin F2 receptor negative regulator |
|
affects expression |
ISO |
3 |
100,844,159 |
100,914,089 |
RGD:6480464 |
CTD |
| G |
Ptgis |
prostaglandin I2 (prostacyclin) synthase |
|
affects expression |
ISO |
2 |
167,028,696 |
167,066,037 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
1 |
151,947,254 |
151,955,147 |
RGD:6480464 |
CTD |
| G |
Pth |
parathyroid hormone |
|
decreases expression |
ISO |
7 |
120,529,090 |
120,532,087 |
RGD:6480464 |
CTD |
| G |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
|
multiple interactions |
ISO |
15 |
73,553,575 |
73,589,196 |
RGD:6480464 |
CTD |
| G |
Ptpn13 |
protein tyrosine phosphatase, non-receptor type 13 |
|
increases expression |
ISO |
5 |
103,854,211 |
104,027,380 |
RGD:6480464 |
CTD |
| G |
Ptpn4 |
protein tyrosine phosphatase, non-receptor type 4 |
|
affects expression |
ISO |
1 |
121,554,669 |
121,733,648 |
RGD:6480464 |
CTD |
| G |
Ptpn6 |
protein tyrosine phosphatase, non-receptor type 6 |
|
decreases activity |
ISO |
6 |
124,670,736 |
124,688,727 |
RGD:6480464 |
CTD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
affects expression |
ISO |
7 |
142,729,507 |
142,877,977 |
RGD:6480464 |
CTD |
| G |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
|
multiple interactions |
ISO |
7 |
142,729,507 |
142,877,977 |
RGD:6480464 |
CTD |
| G |
Ptprh |
protein tyrosine phosphatase, receptor type, H |
|
affects expression |
ISO |
7 |
4,500,216 |
4,555,643 |
RGD:6480464 |
CTD |
| G |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
|
affects expression |
ISO |
10 |
115,455,419 |
115,711,985 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin related gene |
|
multiple interactions |
ISO |
3 |
66,023,809 |
66,029,728 |
RGD:6480464 |
CTD |
| G |
Pvrl1 |
poliovirus receptor-related 1 |
|
affects expression |
ISO |
9 |
43,552,659 |
43,615,544 |
RGD:6480464 |
CTD |
| G |
Pyy |
peptide YY |
|
increases expression |
ISO |
11 |
101,967,990 |
101,969,090 |
RGD:6480464 |
CTD |
| G |
Rab11b |
RAB11B, member RAS oncogene family |
|
increases expression |
ISO |
17 |
33,879,429 |
33,897,431 |
RGD:6480464 |
CTD |
| G |
Rab2a |
RAB2A, member RAS oncogene family |
|
increases expression |
ISO |
4 |
8,462,791 |
8,534,849 |
RGD:6480464 |
CTD |
| G |
Rab31 |
RAB31, member RAS oncogene family |
|
affects expression |
ISO |
17 |
66,001,066 |
66,122,092 |
RGD:6480464 |
CTD |
| G |
Rab40c |
Rab40c, member RAS oncogene family |
|
increases expression |
ISO |
17 |
26,019,059 |
26,056,659 |
RGD:6480464 |
CTD |
| G |
Racgap1 |
Rac GTPase-activating protein 1 |
|
decreases expression |
ISO |
15 |
99,450,927 |
99,482,052 |
RGD:6480464 |
CTD |
| G |
Rap1a |
RAS-related protein-1a |
|
decreases expression |
ISO |
3 |
105,531,200 |
105,604,254 |
RGD:6480464 |
CTD |
| G |
Rara |
retinoic acid receptor, alpha |
|
affects expression |
ISO |
11 |
98,799,010 |
98,836,256 |
RGD:6480464 |
CTD |
| G |
Rasa1 |
RAS p21 protein activator 1 |
|
increases expression |
ISO |
13 |
85,354,304 |
85,429,091 |
RGD:6480464 |
CTD |
| G |
Rasef |
RAS and EF hand domain containing |
|
decreases expression |
ISO |
4 |
73,360,483 |
73,436,506 |
RGD:6480464 |
CTD |
| G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
|
affects expression |
ISO |
9 |
89,804,613 |
89,921,817 |
RGD:6480464 |
CTD |
| G |
Rasgrp1 |
RAS guanyl releasing protein 1 |
|
multiple interactions |
ISO |
2 |
117,105,729 |
117,168,613 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rbbp7 |
retinoblastoma binding protein 7 |
|
decreases expression |
ISO |
X |
159,198,304 |
159,217,022 |
RGD:6480464 |
CTD |
| G |
Rbm10 |
RNA binding motif protein 10 |
|
increases expression |
ISO |
X |
20,194,629 |
20,228,031 |
RGD:6480464 |
CTD |
| G |
Rcan2 |
regulator of calcineurin 2 |
|
multiple interactions |
ISO |
17 |
43,938,800 |
44,176,465 |
RGD:6480464 |
CTD |
| G |
Rcor3 |
REST corepressor 3 |
|
multiple interactions |
ISO |
1 |
193,924,340 |
193,961,669 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
multiple interactions |
ISO |
6 |
118,101,766 |
118,147,762 |
RGD:6480464 |
CTD |
| G |
Rfk |
riboflavin kinase |
|
affects expression |
ISO |
19 |
17,468,533 |
17,475,839 |
RGD:6480464 |
CTD |
| G |
Rfk |
riboflavin kinase |
|
multiple interactions |
ISO |
19 |
17,468,533 |
17,475,839 |
RGD:6480464 |
CTD |
| G |
Rftn1 |
raftlin lipid raft linker 1 |
|
multiple interactions |
ISO |
17 |
50,132,632 |
50,329,822 |
RGD:6480464 |
CTD |
| G |
Rgl1 |
ral guanine nucleotide dissociation stimulator,-like 1 |
|
multiple interactions |
ISO |
1 |
154,364,660 |
154,472,241 |
RGD:6480464 |
CTD |
| G |
Rgs10 |
regulator of G-protein signalling 10 |
|
affects expression |
ISO |
7 |
135,517,139 |
135,561,686 |
RGD:6480464 |
CTD |
| G |
Rgs13 |
regulator of G-protein signaling 13 |
|
affects expression |
ISO |
1 |
145,985,797 |
146,024,502 |
RGD:6480464 |
CTD |
| G |
Rgs16 |
regulator of G-protein signaling 16 |
|
multiple interactions |
ISO |
1 |
155,587,483 |
155,592,598 |
RGD:6480464 |
CTD |
| G |
Rgs4 |
regulator of G-protein signaling 4 |
|
multiple interactions |
ISO |
1 |
171,671,608 |
171,677,773 |
RGD:6480464 |
CTD |
| G |
Rhoa |
ras homolog gene family, member A |
|
decreases expression |
ISO |
9 |
108,208,536 |
108,240,270 |
RGD:6480464 |
CTD |
| G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
|
affects expression |
ISO |
13 |
76,006,985 |
76,081,272 |
RGD:6480464 |
CTD |
| G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
|
multiple interactions |
ISO |
13 |
76,006,985 |
76,081,272 |
RGD:6480464 |
CTD |
| G |
Rhof |
ras homolog gene family, member f |
|
multiple interactions |
ISO |
5 |
123,568,189 |
123,582,638 |
RGD:6480464 |
CTD |
| G |
Rnd3 |
Rho family GTPase 3 |
|
decreases expression |
ISO |
2 |
50,985,959 |
51,004,631 |
RGD:6480464 |
CTD |
| G |
Rnf130 |
ring finger protein 130 |
|
decreases expression |
ISO |
11 |
49,838,833 |
49,918,237 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
decreases expression |
ISO |
18 |
10,064,399 |
10,181,790 |
RGD:6480464 |
CTD |
| G |
Rock2 |
Rho-associated coiled-coil containing protein kinase 2 |
|
decreases expression |
ISO |
12 |
16,901,784 |
16,995,080 |
RGD:6480464 |
CTD |
| G |
Rom1 |
rod outer segment membrane protein 1 |
|
increases expression |
ISO |
19 |
9,001,872 |
9,003,846 |
RGD:6480464 |
CTD |
| G |
Rpl6 |
ribosomal protein L6 |
|
decreases expression |
ISO |
5 |
121,654,510 |
121,659,250 |
RGD:6480464 |
CTD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase, polypeptide 2 |
|
multiple interactions |
ISO |
17 |
7,374,464 |
7,507,664 |
RGD:6480464 |
CTD |
| G |
Rrad |
Ras-related associated with diabetes |
|
multiple interactions |
ISO |
8 |
107,151,966 |
107,155,221 |
RGD:6480464 |
CTD |
| G |
Rras |
Harvey rat sarcoma oncogene, subgroup R |
|
affects expression |
ISO |
7 |
52,273,377 |
52,277,014 |
RGD:6480464 |
CTD |
| G |
Rrm1 |
ribonucleotide reductase M1 |
|
decreases expression |
ISO |
7 |
109,590,209 |
109,618,285 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt related transcription factor 2 |
|
affects expression |
EXP |
17 |
44,740,950 |
44,951,746 |
RGD:6480464 |
CTD |
| G |
Rxrb |
retinoid X receptor beta |
|
increases expression |
ISO |
17 |
34,168,797 |
34,175,344 |
RGD:6480464 |
CTD |
| G |
Ryr1 |
ryanodine receptor 1, skeletal muscle |
|
affects expression |
ISO |
7 |
29,788,359 |
29,910,170 |
RGD:6480464 |
CTD |
| G |
Safb |
scaffold attachment factor B |
|
increases expression |
ISO |
17 |
56,724,405 |
56,745,717 |
RGD:6480464 |
CTD |
| G |
Sall1 |
sal-like 1 (Drosophila) |
|
multiple interactions |
ISO |
8 |
91,551,141 |
91,568,061 |
RGD:6480464 |
CTD |
| G |
Scd2 |
stearoyl-Coenzyme A desaturase 2 |
|
affects expression |
ISO |
19 |
44,368,166 |
44,381,354 |
RGD:6480464 |
CTD |
| G |
Scn4a |
sodium channel, voltage-gated, type IV, alpha |
|
affects expression |
ISO |
11 |
106,179,907 |
106,210,704 |
RGD:6480464 |
CTD |
| G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions |
ISO |
6 |
125,271,358 |
125,294,961 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
affects expression |
ISO |
12 |
8,778,202 |
8,800,494 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
multiple interactions |
ISO |
9 |
107,500,446 |
107,511,572 |
RGD:6480464 |
CTD |
| G |
Sema3b |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
increases expression |
ISO |
9 |
107,500,446 |
107,511,572 |
RGD:6480464 |
CTD |
| G |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
|
multiple interactions |
ISO |
9 |
107,583,833 |
107,612,806 |
RGD:6480464 |
CTD |
| G |
Sema4b |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
|
decreases expression |
ISO |
7 |
87,331,727 |
87,371,410 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
|
decreases expression |
ISO |
1 |
109,408,000 |
109,422,177 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
|
increases expression |
ISO |
1 |
109,408,000 |
109,422,177 |
RGD:6480464 |
CTD |
| G |
Serpinb6a |
serine (or cysteine) peptidase inhibitor, clade B, member 6a |
|
multiple interactions |
ISO |
13 |
34,009,787 |
34,094,618 |
RGD:6480464 |
CTD |
| G |
Serpinb9 |
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
|
affects binding |
ISO |
13 |
33,096,410 |
33,109,824 |
RGD:6480464 |
CTD |
| G |
Serpinb9 |
serine (or cysteine) peptidase inhibitor, clade B, member 9 |
|
multiple interactions |
ISO |
13 |
33,096,410 |
33,109,824 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
multiple interactions |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
decreases expression |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
increases expression |
ISO |
5 |
137,537,374 |
137,548,142 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
|
affects expression |
ISO |
1 |
79,790,896 |
79,855,240 |
RGD:6480464 |
CTD |
| G |
Serpine2 |
serine (or cysteine) peptidase inhibitor, clade E, member 2 |
|
affects expression |
ISO |
1 |
79,790,896 |
79,855,240 |
RGD:6480464 |
CTD |
| G |
Serpinh1 |
serine (or cysteine) peptidase inhibitor, clade H, member 1 |
|
affects expression |
ISO |
7 |
106,493,885 |
106,501,749 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
|
decreases expression |
ISO |
4 |
126,698,545 |
126,708,480 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
affects expression |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
ISO |
10 |
21,601,990 |
21,719,709 |
RGD:6480464 |
CTD |
| G |
Shb |
src homology 2 domain-containing transforming protein B |
|
affects expression |
ISO |
4 |
45,436,148 |
45,543,700 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
increases expression |
ISO |
11 |
69,428,318 |
69,431,407 |
RGD:6480464 |
CTD |
| G |
Shbg |
sex hormone binding globulin |
|
increases expression |
ISO |
11 |
69,428,318 |
69,431,407 |
RGD:6480464 |
CTD |
| G |
Slc17a7 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
decreases expression |
ISO |
7 |
52,419,291 |
52,431,509 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
affects expression |
ISO |
19 |
59,335,368 |
59,370,502 |
RGD:6480464 |
CTD |
| G |
Slc18a3 |
solute carrier family 18 (vesicular monoamine), member 3 |
|
multiple interactions |
ISO |
14 |
33,275,623 |
33,278,036 |
RGD:6480464 |
CTD |
| G |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
|
affects expression |
ISO |
10 |
76,496,004 |
76,513,171 |
RGD:6480464 |
CTD |
| G |
Slc22a5 |
solute carrier family 22 (organic cation transporter), member 5 |
|
affects expression |
ISO |
11 |
53,678,044 |
53,705,205 |
RGD:6480464 |
CTD |
| G |
Slc25a10 |
solute carrier family 25 (mitochondrial carrier, dicarboxylate transporter), member 10 |
|
increases expression |
ISO |
11 |
120,353,151 |
120,362,475 |
RGD:6480464 |
CTD |
| G |
Slc26a2 |
solute carrier family 26 (sulfate transporter), member 2 |
|
decreases expression |
ISO |
18 |
61,356,508 |
61,371,250 |
RGD:6480464 |
CTD |
| G |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
|
affects expression |
ISO |
6 |
122,677,827 |
122,692,763 |
RGD:6480464 |
CTD |
| G |
Slc2a4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression |
ISO |
11 |
69,755,788 |
69,761,692 |
RGD:6480464 |
CTD |
| G |
Slc38a2 |
solute carrier family 38, member 2 |
|
increases expression |
ISO |
15 |
96,517,823 |
96,530,129 |
RGD:6480464 |
CTD |
| G |
Slc39a6 |
solute carrier family 39 (metal ion transporter), member 6 |
|
decreases expression |
ISO |
18 |
24,738,382 |
24,762,318 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
ISO |
19 |
8,781,372 |
8,797,859 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
ISO |
13 |
73,674,195 |
73,716,120 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects expression |
ISO |
11 |
76,812,099 |
76,845,845 |
RGD:6480464 |
CTD |
| G |
Slc6a4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions |
ISO |
11 |
76,812,099 |
76,845,845 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
|
increases expression |
ISO |
3 |
50,168,858 |
50,247,535 |
RGD:6480464 |
CTD |
| G |
Slc7a4 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 4 |
|
affects expression |
ISO |
16 |
17,572,111 |
17,576,764 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 |
|
affects expression |
ISO |
11 |
115,024,655 |
115,042,492 |
RGD:6480464 |
CTD |
| G |
Slco4c1 |
solute carrier organic anion transporter family, member 4C1 |
|
multiple interactions |
ISO |
1 |
98,715,361 |
98,768,748 |
RGD:6480464 |
CTD |
| G |
Slit1 |
slit homolog 1 (Drosophila) |
|
affects expression |
ISO |
19 |
41,674,747 |
41,818,346 |
RGD:6480464 |
CTD |
| G |
Sln |
sarcolipin |
|
multiple interactions |
ISO |
9 |
53,698,058 |
53,701,656 |
RGD:6480464 |
CTD |
| G |
Smad7 |
SMAD family member 7 |
|
affects expression |
ISO |
18 |
75,527,019 |
75,555,588 |
RGD:6480464 |
CTD |
| G |
Smurf2 |
SMAD specific E3 ubiquitin protein ligase 2 |
|
decreases expression |
ISO |
11 |
106,681,378 |
106,782,029 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha |
|
affects expression |
ISO |
6 |
60,681,567 |
60,779,849 |
RGD:6480464 |
CTD |
| G |
Snn |
stannin |
|
affects expression |
ISO |
16 |
11,066,391 |
11,075,078 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases expression |
ISO |
16 |
90,220,987 |
90,226,569 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
17 |
13,200,705 |
13,210,985 |
RGD:6480464 |
CTD |
| G |
Sod3 |
superoxide dismutase 3, extracellular |
|
increases expression |
ISO |
5 |
52,755,043 |
52,760,977 |
RGD:6480464 |
CTD |
| G |
Son |
Son DNA binding protein |
|
decreases expression |
ISO |
16 |
91,648,069 |
91,679,437 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted acidic cysteine rich glycoprotein |
|
affects expression |
ISO |
11 |
55,208,003 |
55,233,582 |
RGD:6480464 |
CTD |
| G |
Spata13 |
spermatogenesis associated 13 |
|
increases expression |
ISO |
14 |
61,253,566 |
61,383,393 |
RGD:6480464 |
CTD |
| G |
Spn |
sialophorin |
|
affects expression |
ISO |
7 |
134,276,978 |
134,281,331 |
RGD:6480464 |
CTD |
| G |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
|
increases expression |
ISO |
8 |
65,430,243 |
65,835,895 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
affects expression |
ISO |
5 |
104,869,403 |
104,879,477 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
ISO |
11 |
50,013,654 |
50,024,292 |
RGD:6480464 |
CTD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
multiple interactions |
ISO |
11 |
60,012,591 |
60,034,106 |
RGD:6480464 |
CTD |
| G |
Srpk2 |
serine/arginine-rich protein specific kinase 2 |
|
affects expression |
ISO |
5 |
23,009,174 |
23,122,389 |
RGD:6480464 |
CTD |
| G |
Srsf1 |
serine/arginine-rich splicing factor 1 |
|
decreases expression |
ISO |
11 |
87,861,173 |
87,867,259 |
RGD:6480464 |
CTD |
| G |
Srsf3 |
serine/arginine-rich splicing factor 3 |
|
affects expression |
ISO |
17 |
29,169,618 |
29,180,311 |
RGD:6480464 |
CTD |
| G |
Ssh1 |
slingshot homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
5 |
114,392,228 |
114,443,766 |
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
multiple interactions |
ISO |
15 |
66,934,437 |
67,008,444 |
RGD:6480464 |
CTD |
| G |
St3gal2 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
|
increases expression |
ISO |
8 |
113,443,765 |
113,496,397 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
decreases expression |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
multiple interactions |
ISO |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Stbd1 |
starch binding domain 1 |
|
affects expression |
ISO |
5 |
93,032,077 |
93,035,605 |
RGD:6480464 |
CTD |
| G |
Stc2 |
stanniocalcin 2 |
|
increases expression |
ISO |
11 |
31,259,441 |
31,270,061 |
RGD:6480464 |
CTD |
| G |
Stk24 |
serine/threonine kinase 24 |
|
affects expression |
ISO |
14 |
121,685,563 |
121,778,452 |
RGD:6480464 |
CTD |
| G |
Stk24 |
serine/threonine kinase 24 |
|
multiple interactions |
ISO |
14 |
121,685,563 |
121,778,452 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
decreases expression |
ISO |
4 |
134,024,235 |
134,029,758 |
RGD:6480464 |
CTD |
| G |
Stx16 |
syntaxin 16 |
|
increases expression |
ISO |
2 |
173,902,552 |
173,925,272 |
RGD:6480464 |
CTD |
| G |
Stx1a |
syntaxin 1A (brain) |
|
increases expression |
ISO |
5 |
135,499,442 |
135,526,969 |
RGD:6480464 |
CTD |
| G |
Sult5a1 |
sulfotransferase family 5A, member 1 |
|
affects expression |
ISO |
8 |
125,666,747 |
125,682,180 |
RGD:6480464 |
CTD |
| G |
Sult5a1 |
sulfotransferase family 5A, member 1 |
|
affects expression |
ISO |
8 |
125,666,747 |
125,682,180 |
RGD:6480464 |
CTD |
| G |
Sybu |
syntabulin (syntaxin-interacting) |
|
multiple interactions |
ISO |
15 |
44,503,402 |
44,619,609 |
RGD:6480464 |
CTD |
| G |
Synj2 |
synaptojanin 2 |
|
multiple interactions |
ISO |
17 |
5,941,280 |
6,044,290 |
RGD:6480464 |
CTD |
| G |
Synpo |
synaptopodin |
|
multiple interactions |
ISO |
18 |
60,753,644 |
60,783,959 |
RGD:6480464 |
CTD |
| G |
T |
brachyury |
|
increases expression |
ISO |
17 |
8,627,288 |
8,635,361 |
RGD:6480464 |
CTD |
| G |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
|
affects expression |
ISO |
8 |
26,265,024 |
26,311,921 |
RGD:6480464 |
CTD |
| G |
Tacc1 |
transforming, acidic coiled-coil containing protein 1 |
|
multiple interactions |
ISO |
8 |
26,265,024 |
26,311,921 |
RGD:6480464 |
CTD |
| G |
Tacc2 |
transforming, acidic coiled-coil containing protein 2 |
|
multiple interactions |
ISO |
7 |
137,720,998 |
137,908,298 |
RGD:6480464 |
CTD |
| G |
Taf9 |
TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression |
ISO |
13 |
101,421,298 |
101,436,368 |
RGD:6480464 |
CTD |
| G |
Taok3 |
TAO kinase 3 |
|
increases expression |
ISO |
5 |
117,583,604 |
117,723,924 |
RGD:6480464 |
CTD |
| G |
Tars |
threonyl-tRNA synthetase |
|
decreases expression |
ISO |
15 |
11,313,418 |
11,329,413 |
RGD:6480464 |
CTD |
| G |
Tbx2 |
T-box 2 |
|
increases expression |
ISO |
11 |
85,646,117 |
85,655,450 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
multiple interactions |
ISO |
10 |
80,791,476 |
80,797,917 |
RGD:6480464 |
CTD |
| G |
Tceb2 |
transcription elongation factor B (SIII), polypeptide 2 |
|
decreases expression |
ISO |
17 |
23,961,707 |
23,966,076 |
RGD:6480464 |
CTD |
| G |
Tcp1 |
t-complex protein 1 |
|
affects expression |
ISO |
17 |
13,109,331 |
13,117,933 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
multiple interactions |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases expression |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
increases phosphorylation |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
multiple interactions |
ISO |
13 |
73,764,449 |
73,786,489 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
multiple interactions |
ISO |
10 |
70,688,225 |
70,700,792 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
increases expression |
ISO |
10 |
70,688,225 |
70,700,792 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
affects binding |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
decreases expression |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
decreases expression |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
17 |
31,298,341 |
31,301,998 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
affects expression |
ISO |
17 |
31,262,251 |
31,266,556 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
decreases expression |
ISO |
17 |
31,262,251 |
31,266,556 |
RGD:6480464 |
CTD |
| G |
Tfpi |
tissue factor pathway inhibitor |
|
multiple interactions |
ISO |
2 |
84,273,017 |
84,316,932 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
multiple interactions |
ISO |
6 |
86,145,245 |
86,225,443 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
7 |
26,472,021 |
26,490,015 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
affects expression |
ISO |
1 |
188,447,065 |
188,529,871 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
1 |
188,447,065 |
188,529,871 |
RGD:6480464 |
CTD |
| G |
Tgfb2 |
transforming growth factor, beta 2 |
|
multiple interactions |
ISO |
1 |
188,447,065 |
188,529,871 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
multiple interactions |
ISO |
12 |
87,397,693 |
87,419,991 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
affects expression |
ISO |
12 |
87,397,693 |
87,419,991 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
multiple interactions |
ISO |
13 |
56,710,964 |
56,740,700 |
RGD:6480464 |
CTD |
| G |
Tgfbi |
transforming growth factor, beta induced |
|
affects expression |
ISO |
13 |
56,710,964 |
56,740,700 |
RGD:6480464 |
CTD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
affects expression |
ISO |
9 |
115,996,813 |
116,084,481 |
RGD:6480464 |
CTD |
| G |
Tgm2 |
transglutaminase 2, C polypeptide |
|
affects expression |
ISO |
2 |
157,942,141 |
157,972,128 |
RGD:6480464 |
CTD |
| G |
Thbs2 |
thrombospondin 2 |
|
decreases expression |
ISO |
17 |
14,802,507 |
14,831,269 |
RGD:6480464 |
CTD |
| G |
Thy1 |
thymus cell antigen 1, theta |
|
affects expression |
ISO |
9 |
43,851,467 |
43,856,662 |
RGD:6480464 |
CTD |
| G |
Thy1 |
thymus cell antigen 1, theta |
|
increases expression |
ISO |
9 |
43,851,467 |
43,856,662 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
increases expression |
ISO |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Timp1 |
tissue inhibitor of metalloproteinase 1 |
|
affects expression |
ISO |
X |
20,447,292 |
20,451,863 |
RGD:6480464 |
CTD |
| G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
|
multiple interactions |
ISO |
3 |
65,332,369 |
65,359,440 |
RGD:6480464 |
CTD |
| G |
Tle1 |
transducin-like enhancer of split 1, homolog of Drosophila E(spl) |
|
affects expression |
ISO |
4 |
71,778,176 |
71,861,953 |
RGD:6480464 |
CTD |
| G |
Tmem158 |
transmembrane protein 158 |
|
affects expression |
ISO |
9 |
123,168,175 |
123,169,907 |
RGD:6480464 |
CTD |
| G |
Tmem158 |
transmembrane protein 158 |
|
multiple interactions |
ISO |
9 |
123,168,175 |
123,169,907 |
RGD:6480464 |
CTD |
| G |
Tmod1 |
tropomodulin 1 |
|
affects expression |
ISO |
4 |
46,052,094 |
46,128,904 |
RGD:6480464 |
CTD |
| G |
Tmod1 |
tropomodulin 1 |
|
multiple interactions |
ISO |
4 |
46,052,094 |
46,128,904 |
RGD:6480464 |
CTD |
| G |
Tmpo |
thymopoietin |
|
decreases expression |
ISO |
10 |
90,610,316 |
90,634,327 |
RGD:6480464 |
CTD |
| G |
Tmprss3 |
transmembrane protease, serine 3 |
|
multiple interactions |
ISO |
17 |
31,316,210 |
31,335,919 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfaip3 |
tumor necrosis factor, alpha-induced protein 3 |
|
decreases expression |
ISO |
10 |
18,720,716 |
18,735,216 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11a |
tumor necrosis factor receptor superfamily, member 11a |
|
decreases expression |
ISO |
1 |
107,677,300 |
107,744,558 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
multiple interactions |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
decreases expression |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
multiple interactions |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
increases expression |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
|
increases expression |
ISO |
15 |
54,082,174 |
54,110,039 |
RGD:6480464 |
CTD |
| G |
Tnfrsf21 |
tumor necrosis factor receptor superfamily, member 21 |
|
multiple interactions |
ISO |
17 |
43,153,504 |
43,226,137 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression |
ISO |
4 |
151,490,452 |
151,494,220 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression |
ISO |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf15 |
tumor necrosis factor (ligand) superfamily, member 15 |
|
increases expression |
ISO |
4 |
63,385,637 |
63,406,147 |
RGD:6480464 |
CTD |
| G |
Tnik |
TRAF2 and NCK interacting kinase |
|
multiple interactions |
ISO |
3 |
28,162,136 |
28,569,507 |
RGD:6480464 |
CTD |
| G |
Tnni3 |
troponin I, cardiac 3 |
|
affects expression |
ISO |
7 |
4,469,910 |
4,474,045 |
RGD:6480464 |
CTD |
| G |
Tnpo1 |
transportin 1 |
|
decreases expression |
ISO |
13 |
99,612,036 |
99,696,339 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
multiple interactions |
ISO |
11 |
94,072,768 |
94,076,809 |
RGD:6480464 |
CTD |
| G |
Tom1 |
target of myb1 homolog (chicken) |
|
affects expression |
ISO |
8 |
77,557,585 |
77,594,020 |
RGD:6480464 |
CTD |
| G |
Top1 |
topoisomerase (DNA) I |
|
decreases expression |
ISO |
2 |
160,471,633 |
160,548,500 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
affects expression |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Tpm1 |
tropomyosin 1, alpha |
|
affects expression |
ISO |
9 |
66,870,400 |
66,897,020 |
RGD:6480464 |
CTD |
| G |
Traf3ip2 |
TRAF3 interacting protein 2 |
|
multiple interactions |
ISO |
10 |
39,332,740 |
39,375,113 |
RGD:6480464 |
CTD |
| G |
Traf5 |
TNF receptor-associated factor 5 |
|
multiple interactions |
ISO |
1 |
193,878,227 |
193,916,445 |
RGD:6480464 |
CTD |
| G |
Trak2 |
trafficking protein, kinesin binding 2 |
|
decreases expression |
ISO |
1 |
58,957,294 |
59,030,326 |
RGD:6480464 |
CTD |
| G |
Trib1 |
tribbles homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
15 |
59,480,209 |
59,488,654 |
RGD:6480464 |
CTD |
| G |
Trib2 |
tribbles homolog 2 (Drosophila) |
|
affects expression |
ISO |
12 |
15,798,533 |
15,823,591 |
RGD:6480464 |
CTD |
| G |
Trim25 |
tripartite motif-containing 25 |
|
multiple interactions |
ISO |
11 |
88,860,717 |
88,881,607 |
RGD:6480464 |
CTD |
| G |
Trim36 |
tripartite motif-containing 36 |
|
multiple interactions |
ISO |
18 |
46,324,954 |
46,372,261 |
RGD:6480464 |
CTD |
| G |
Trp53i11 |
transformation related protein 53 inducible protein 11 |
|
affects expression |
ISO |
2 |
93,027,741 |
93,041,914 |
RGD:6480464 |
CTD |
| G |
Trp53inp1 |
transformation related protein 53 inducible nuclear protein 1 |
|
multiple interactions |
ISO |
4 |
11,083,588 |
11,101,524 |
RGD:6480464 |
CTD |
| G |
Trp73 |
transformation related protein 73 |
|
decreases expression |
ISO |
4 |
153,430,358 |
153,514,317 |
RGD:6480464 |
CTD |
| G |
Twf2 |
twinfilin, actin-binding protein, homolog 2 (Drosophila) |
|
affects expression |
ISO |
9 |
106,105,439 |
106,117,718 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases expression |
ISO |
10 |
82,296,696 |
82,360,469 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
affects expression |
ISO |
11 |
62,365,006 |
62,366,714 |
RGD:6480464 |
CTD |
| G |
Ube3c |
ubiquitin protein ligase E3C |
|
decreases expression |
ISO |
5 |
29,895,782 |
30,002,617 |
RGD:6480464 |
CTD |
| G |
Ung |
uracil DNA glycosylase |
|
decreases expression |
ISO |
5 |
114,580,444 |
114,589,330 |
RGD:6480464 |
CTD |
| G |
Upf1 |
UPF1 regulator of nonsense transcripts homolog (yeast) |
|
affects expression |
ISO |
8 |
72,855,421 |
72,877,172 |
RGD:6480464 |
CTD |
| G |
Upf1 |
UPF1 regulator of nonsense transcripts homolog (yeast) |
|
multiple interactions |
ISO |
8 |
72,855,421 |
72,877,172 |
RGD:6480464 |
CTD |
| G |
Usp32 |
ubiquitin specific peptidase 32 |
|
decreases expression |
ISO |
11 |
84,797,990 |
84,953,457 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
multiple interactions |
ISO |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
affects response to substance |
ISO |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vdr |
vitamin D receptor |
|
affects response to substance |
ISO |
15 |
97,684,858 |
97,738,727 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vwf |
Von Willebrand factor homolog |
|
increases expression |
ISO |
6 |
125,502,981 |
125,636,695 |
RGD:6480464 |
CTD |
| G |
Was |
Wiskott-Aldrich syndrome homolog (human) |
|
decreases expression |
ISO |
X |
7,658,592 |
7,667,617 |
RGD:6480464 |
CTD |
| G |
Wdr1 |
WD repeat domain 1 |
|
affects expression |
ISO |
5 |
38,918,052 |
38,952,834 |
RGD:6480464 |
CTD |
| G |
Wfdc1 |
WAP four-disulfide core domain 1 |
|
increases expression |
ISO |
8 |
122,190,265 |
122,211,920 |
RGD:6480464 |
CTD |
| G |
Wnt11 |
wingless-related MMTV integration site 11 |
|
decreases expression |
ISO |
7 |
105,987,355 |
106,003,257 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-related MMTV integration site 5A |
|
multiple interactions |
ISO |
14 |
29,318,659 |
29,338,620 |
RGD:6480464 |
CTD |
| G |
Wwc1 |
WW, C2 and coiled-coil domain containing 1 |
|
affects expression |
ISO |
11 |
35,652,680 |
35,793,591 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases activity |
ISO |
17 |
74,233,248 |
74,299,522 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
multiple interactions |
ISO |
17 |
74,233,248 |
74,299,522 |
RGD:6480464 |
CTD |
| G |
Xpo1 |
exportin 1, CRM1 homolog (yeast) |
|
decreases expression |
ISO |
11 |
23,156,041 |
23,197,597 |
RGD:6480464 |
CTD |
| G |
Xrcc5 |
X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
decreases expression |
ISO |
1 |
72,353,995 |
72,441,527 |
RGD:6480464 |
CTD |
| G |
Ybx3 |
Y box protein 3 |
|
affects expression |
ISO |
6 |
131,314,876 |
131,338,468 |
RGD:6480464 |
CTD |
| G |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
|
affects expression |
ISO |
14 |
26,531,126 |
26,588,342 |
RGD:6480464 |
CTD |
| G |
Zcchc24 |
zinc finger, CCHC domain containing 24 |
|
multiple interactions |
ISO |
14 |
26,531,126 |
26,588,342 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
decreases expression |
ISO |
18 |
5,591,889 |
5,774,909 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
multiple interactions |
ISO |
7 |
29,161,803 |
29,164,247 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
affects expression |
ISO |
7 |
29,161,803 |
29,164,247 |
RGD:6480464 |
CTD |
| G |
Zfp395 |
zinc finger protein 395 |
|
multiple interactions |
ISO |
14 |
65,977,513 |
66,017,767 |
RGD:6480464 |
CTD |
| G |
Zfx |
zinc finger protein X-linked |
|
increases expression |
ISO |
X |
91,319,970 |
91,368,746 |
RGD:6480464 |
CTD |
| G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
|
affects expression |
ISO |
14 |
26,278,778 |
26,484,205 |
RGD:6480464 |
CTD |
| G |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
|
multiple interactions |
ISO |
14 |
26,278,778 |
26,484,205 |
RGD:6480464 |
CTD |
| G |
Zmym2 |
zinc finger, MYM-type 2 |
|
increases expression |
ISO |
14 |
57,506,631 |
57,579,186 |
RGD:6480464 |
CTD |
Term paths to the root
|